| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.783 | 0.004 | 0.91 | 5 Hydroxytryptamine release stimulant | 0.76 0.004 DBMET00258 0.91 0.002 DBMET01359 0.797 0.004 DBMET00411 0.338 0.059 DBMET00763 0.686 0.008 DBMET00762 0.838 0.003 DBMET01360 0.843 0.003 DBMET01361 0.352 0.056 DBMET00926 0.718 0.006 DBMET00925 0.837 0.003 DBMET01362 | DBMET01359 | |
| 0.677 | 0.001 | 0.677 | Melatonin receptor 1A agonist | 0.085 0.004 DBMET00258 0.206 0.002 DBMET01359 0.266 0.002 DBMET00411 0.033 0.023 DBMET00763 0.033 0.024 DBMET00762 0.05 0.008 DBMET01360 0.103 0.003 DBMET01361 0.105 0.003 DBMET00926 0.035 0.019 DBMET00925 0.144 0.003 DBMET01362 | ||
| 0.638 | 0.002 | 0.638 | Melatonin 1 agonist | 0.091 0.004 DBMET00258 0.117 0.004 DBMET01359 0.476 0.003 DBMET00411 0.046 0.011 DBMET00763 0.154 0.004 DBMET00762 0.038 0.017 DBMET01360 0.073 0.005 DBMET01361 0.172 0.003 DBMET00926 0.15 0.004 DBMET00925 0.087 0.004 DBMET01362 | ||
| 0.622 | 0.002 | 0.622 | Melatonin agonist | 0.106 0.005 DBMET00258 0.166 0.004 DBMET01359 0.457 0.003 DBMET00411 0.04 0.015 DBMET00763 0.203 0.004 DBMET00762 0.037 0.017 DBMET01360 0.075 0.005 DBMET01361 0.23 0.004 DBMET00926 0.192 0.004 DBMET00925 0.104 0.005 DBMET01362 | ||
| 0.619 | 0.001 | 0.619 | Melatonin receptor 1A antagonist | 0.017 0.007 DBMET00258 0.07 0.003 DBMET01359 0.14 0.002 DBMET00411 0.02 0.005 DBMET01360 0.02 0.005 DBMET00926 0.026 0.005 DBMET01362 | ||
| 0.58 | 0.003 | 0.58 | Melatonin antagonist | 0.06 0.006 DBMET00258 0.142 0.004 DBMET01359 0.385 0.003 DBMET00411 0.071 0.005 DBMET00762 0.053 0.007 DBMET01360 0.045 0.009 DBMET01361 0.157 0.004 DBMET00926 0.069 0.005 DBMET00925 0.083 0.005 DBMET01362 | ||
| 0.568 | 0.002 | 0.568 | Melatonin 2 agonist | 0.097 0.005 DBMET00258 0.099 0.004 DBMET01359 0.455 0.003 DBMET00411 0.04 0.015 DBMET00763 0.2 0.003 DBMET00762 0.033 0.022 DBMET01360 0.058 0.008 DBMET01361 0.183 0.004 DBMET00926 0.193 0.003 DBMET00925 0.06 0.008 DBMET01362 | ||
| 0.581 | 0.039 | 0.787 | Caspase 9 stimulant | 0.787 0.013 DBMET00258 0.647 0.03 DBMET01359 0.536 0.048 DBMET00411 0.253 0.25 DBMET00763 0.648 0.03 DBMET00762 0.631 0.032 DBMET01360 0.604 0.036 DBMET01361 0.508 0.057 DBMET00925 0.492 0.063 DBMET01362 | DBMET00258 | |
| 0.556 | 0.015 | 0.605 | Interleukin antagonist | 0.378 0.034 DBMET00258 0.509 0.019 DBMET01359 0.605 0.012 DBMET00411 0.397 0.031 DBMET00762 0.49 0.021 DBMET01361 0.281 0.052 DBMET00926 0.428 0.027 DBMET00925 0.485 0.021 DBMET01362 | DBMET00411 | |
| 0.505 | 0.003 | 0.505 | Melatonin 1 antagonist | 0.032 0.006 DBMET00258 0.083 0.004 DBMET01359 0.304 0.003 DBMET00411 0.044 0.005 DBMET00762 0.023 0.009 DBMET01360 0.023 0.009 DBMET01361 0.1 0.004 DBMET00926 0.042 0.005 DBMET00925 0.044 0.005 DBMET01362 | ||
| 0.492 | 0.004 | 0.711 | 5 Hydroxytryptamine 1E antagonist | 0.325 0.017 DBMET00258 0.641 0.003 DBMET01359 0.453 0.004 DBMET00411 0.18 0.154 DBMET00763 0.308 0.025 DBMET01360 0.708 0.002 DBMET01361 0.299 0.03 DBMET00926 0.711 0.002 DBMET01362 | DBMET01362 | |
| 0.444 | 0.017 | 0.62 | Psychostimulant | 0.253 0.057 DBMET00258 0.505 0.01 DBMET01359 0.46 0.015 DBMET00411 0.447 0.016 DBMET00762 0.541 0.008 DBMET01360 0.576 0.007 DBMET01361 0.467 0.014 DBMET00925 0.62 0.005 DBMET01362 | DBMET01362 | |
| 0.45 | 0.041 | 0.493 | Vasodilator, peripheral | 0.382 0.061 DBMET00258 0.316 0.089 DBMET01359 0.44 0.044 DBMET00411 0.493 0.029 DBMET00762 0.464 0.036 DBMET01360 0.468 0.035 DBMET01361 0.419 0.049 DBMET00925 0.462 0.037 DBMET01362 | DBMET00762 | |
| 0.397 | 0.001 | 0.397 | Melatonin 2 antagonist | 0.014 0.006 DBMET00258 0.034 0.003 DBMET01359 0.053 0.002 DBMET00411 0.02 0.004 DBMET01360 0.017 0.004 DBMET00926 0.014 0.005 DBMET01362 | ||
| 0.443 | 0.055 | 0.509 | Calcium channel L-type activator | 0.483 0.035 DBMET00258 0.468 0.041 DBMET01359 0.495 0.03 DBMET00411 0.358 0.111 DBMET00763 0.358 0.111 DBMET00762 0.475 0.038 DBMET01360 0.509 0.024 DBMET01361 0.292 0.164 DBMET00926 0.332 0.131 DBMET00925 0.5 0.028 DBMET01362 | DBMET01361 | |
| 0.448 | 0.063 | 0.574 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.281 0.239 DBMET00258 0.45 0.062 DBMET01359 0.444 0.066 DBMET00411 0.415 0.088 DBMET01360 0.449 0.062 DBMET01361 0.266 0.261 DBMET00926 0.574 0.011 DBMET01362 | DBMET01362 | |
| 0.382 | 0.005 | 0.797 | 5 Hydroxytryptamine 1 agonist | 0.248 0.009 DBMET00258 0.733 0.004 DBMET01359 0.323 0.005 DBMET00411 0.079 0.025 DBMET00763 0.392 0.005 DBMET01360 0.645 0.004 DBMET01361 0.107 0.019 DBMET00926 0.797 0.003 DBMET01362 | DBMET01362 | |
| 0.398 | 0.022 | 0.44 | Insulysin inhibitor | 0.339 0.038 DBMET00258 0.374 0.027 DBMET01359 0.44 0.016 DBMET00411 0.412 0.02 DBMET01361 0.326 0.044 DBMET00926 0.407 0.021 DBMET01362 | DBMET00411 | |
| 0.341 | 0.003 | 0.547 | 5 Hydroxytryptamine 3E antagonist | 0.227 0.03 DBMET00258 0.456 0.002 DBMET01359 0.326 0.004 DBMET00411 0.173 0.125 DBMET00763 0.228 0.029 DBMET01360 0.463 0.002 DBMET01361 0.265 0.011 DBMET00926 0.547 0.001 DBMET01362 | DBMET01362 | |
| 0.323 | 0.003 | 0.49 | Myeloperoxidase inhibitor | 0.229 0.004 DBMET00258 0.49 0.002 DBMET01359 0.378 0.003 DBMET00411 0.436 0.003 DBMET01361 0.081 0.064 DBMET00926 0.398 0.003 DBMET01362 | DBMET01359 | |
| 0.321 | 0.008 | 0.345 | Nitric-oxide synthase stimulant | 0.312 0.009 DBMET00258 0.319 0.008 DBMET01359 0.345 0.005 DBMET00411 0.328 0.006 DBMET00762 0.205 0.08 DBMET01360 0.292 0.013 DBMET01361 0.173 0.145 DBMET00926 0.339 0.005 DBMET00925 0.248 0.034 DBMET01362 | DBMET00411 | |
| 0.324 | 0.04 | 0.449 | Amyloid beta aggregation inhibitor | 0.308 0.044 DBMET00258 0.316 0.042 DBMET01359 0.369 0.03 DBMET00411 0.296 0.046 DBMET00762 0.399 0.025 DBMET01360 0.449 0.019 DBMET01361 0.141 0.115 DBMET00926 0.25 0.058 DBMET00925 0.346 0.035 DBMET01362 | DBMET01361 | |
| 0.339 | 0.057 | 0.414 | Calcium channel activator | 0.314 0.079 DBMET00258 0.414 0.02 DBMET01359 0.286 0.106 DBMET00411 0.393 0.027 DBMET01360 0.334 0.062 DBMET01361 0.358 0.045 DBMET01362 | DBMET01359 | |
| 0.361 | 0.08 | 0.558 | GABA C receptor rho-3 antagonist | 0.303 0.114 DBMET00258 0.431 0.049 DBMET01359 0.529 0.019 DBMET00411 0.451 0.041 DBMET01360 0.545 0.015 DBMET01361 0.558 0.013 DBMET01362 | DBMET01362 | |
| 0.277 | 0.004 | 0.312 | Acetylcholine release stimulant | 0.107 0.071 DBMET00258 0.147 0.018 DBMET01359 0.179 0.006 DBMET00411 0.153 0.014 DBMET00763 0.175 0.007 DBMET00762 0.127 0.037 DBMET01361 0.312 0.003 DBMET00926 0.191 0.005 DBMET00925 0.164 0.01 DBMET01362 | DBMET00926 | |
| 0.301 | 0.027 | 0.626 | DNA methylase inhibitor | 0.342 0.018 DBMET00258 0.316 0.023 DBMET01359 0.302 0.027 DBMET00411 0.626 0.004 DBMET00762 0.294 0.03 DBMET01361 0.443 0.008 DBMET00925 0.243 0.052 DBMET01362 | DBMET00762 | |
| 0.294 | 0.029 | 0.605 | DNA methyltransferase I inhibitor | 0.341 0.015 DBMET00258 0.272 0.038 DBMET01359 0.296 0.028 DBMET00411 0.605 0.004 DBMET00762 0.285 0.032 DBMET01361 0.402 0.009 DBMET00925 0.218 0.06 DBMET01362 | DBMET00762 | |
| 0.295 | 0.032 | 0.295 | Calpain inhibitor | 0.192 0.121 DBMET01359 0.294 0.033 DBMET00411 0.163 0.159 DBMET01361 0.166 0.154 DBMET00926 0.204 0.11 DBMET01362 | ||
| 0.263 | 0.007 | 0.314 | Toll-Like receptor 2 antagonist | 0.234 0.012 DBMET00258 0.227 0.014 DBMET01359 0.314 0.004 DBMET00411 0.177 0.035 DBMET00762 0.139 0.061 DBMET01360 0.206 0.021 DBMET01361 0.108 0.092 DBMET00926 0.173 0.038 DBMET00925 0.146 0.056 DBMET01362 | DBMET00411 | |
| 0.264 | 0.01 | 0.712 | 5 Hydroxytryptamine agonist | 0.136 0.024 DBMET00258 0.676 0.004 DBMET01359 0.191 0.015 DBMET00411 0.602 0.004 DBMET01360 0.539 0.004 DBMET01361 0.712 0.004 DBMET01362 | DBMET01362 | |
| 0.268 | 0.018 | 0.298 | Neurotensin receptor agonist | 0.223 0.026 DBMET00258 0.261 0.019 DBMET01359 0.298 0.014 DBMET00411 0.144 0.118 DBMET00763 0.159 0.081 DBMET00762 0.15 0.102 DBMET01360 0.267 0.018 DBMET01361 0.174 0.057 DBMET00926 0.154 0.091 DBMET00925 0.224 0.026 DBMET01362 | DBMET00411 | |
| 0.255 | 0.007 | 0.255 | Falcipain 3 inhibitor | 0.14 0.042 DBMET00258 0.182 0.024 DBMET01359 0.241 0.009 DBMET00411 0.208 0.015 DBMET01361 0.088 0.084 DBMET00926 0.234 0.01 DBMET01362 | ||
| 0.343 | 0.103 | 0.525 | Histamine release inhibitor | 0.313 0.117 DBMET00258 0.291 0.128 DBMET01359 0.436 0.057 DBMET00411 0.521 0.022 DBMET00762 0.232 0.169 DBMET01360 0.438 0.056 DBMET01361 0.325 0.111 DBMET00926 0.525 0.021 DBMET00925 0.36 0.095 DBMET01362 | DBMET00925 | |
| 0.333 | 0.095 | 0.333 | Calpain 2 inhibitor | 0.306 0.11 DBMET00411 | ||
| 0.29 | 0.055 | 0.46 | Antiamyloidogenic | 0.171 0.122 DBMET00258 0.271 0.062 DBMET01359 0.302 0.051 DBMET00411 0.46 0.02 DBMET00762 0.295 0.053 DBMET01360 0.325 0.045 DBMET01361 0.404 0.028 DBMET00925 0.224 0.084 DBMET01362 | DBMET00762 | |
| 0.238 | 0.005 | 0.617 | 5 Hydroxytryptamine 1D antagonist | 0.07 0.039 DBMET00258 0.522 0.003 DBMET01359 0.137 0.014 DBMET00411 0.22 0.005 DBMET01360 0.475 0.003 DBMET01361 0.617 0.003 DBMET01362 | DBMET01362 | |
| 0.273 | 0.044 | 0.331 | Sigma receptor agonist | 0.135 0.098 DBMET00258 0.23 0.053 DBMET01359 0.24 0.051 DBMET00411 0.328 0.034 DBMET01361 0.331 0.033 DBMET01362 | DBMET01362 | |
| 0.252 | 0.027 | 0.252 | 3C-like protease (Human coronavirus) inhibitor | 0.173 0.071 DBMET01359 0.193 0.056 DBMET00411 0.15 0.102 DBMET01360 | ||
| 0.293 | 0.07 | 0.405 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.278 0.081 DBMET00258 0.332 0.044 DBMET01359 0.3 0.064 DBMET00411 0.355 0.034 DBMET01360 0.351 0.036 DBMET01361 0.405 0.02 DBMET01362 | DBMET01362 | |
| 0.224 | 0.017 | 0.224 | Antibacterial (Helicobacter pylori) | 0.161 0.038 DBMET00258 0.142 0.053 DBMET01359 0.217 0.018 DBMET00411 0.123 0.077 DBMET00763 0.146 0.049 DBMET00762 0.141 0.054 DBMET01361 0.206 0.02 DBMET00926 0.13 0.068 DBMET00925 0.15 0.046 DBMET01362 | ||
| 0.296 | 0.09 | 0.485 | Vasodilator, coronary | 0.238 0.146 DBMET00258 0.289 0.097 DBMET01359 0.266 0.119 DBMET00411 0.485 0.018 DBMET00762 0.27 0.115 DBMET01360 0.363 0.049 DBMET01361 0.439 0.025 DBMET00925 0.356 0.052 DBMET01362 | DBMET00762 | |
| 0.273 | 0.07 | 0.384 | Aryl hydrocarbon receptor agonist | 0.276 0.069 DBMET00258 0.384 0.04 DBMET01359 0.227 0.089 DBMET00411 0.271 0.071 DBMET01361 0.289 0.064 DBMET01362 | DBMET01359 | |
| 0.238 | 0.038 | 0.306 | Lipocortins synthesis antagonist | 0.242 0.036 DBMET00258 0.27 0.028 DBMET01359 0.258 0.031 DBMET00411 0.169 0.081 DBMET00763 0.203 0.054 DBMET00762 0.3 0.021 DBMET01361 0.173 0.078 DBMET00926 0.222 0.044 DBMET00925 0.306 0.02 DBMET01362 | DBMET01362 | |
| 0.219 | 0.02 | 0.397 | GABA C receptor rho-2 antagonist | 0.227 0.017 DBMET00258 0.245 0.013 DBMET01359 0.241 0.014 DBMET00411 0.397 0.004 DBMET01360 0.265 0.009 DBMET01361 0.286 0.006 DBMET01362 | DBMET01360 | |
| 0.246 | 0.048 | 0.521 | Peroxidase inhibitor | 0.339 0.03 DBMET00258 0.401 0.02 DBMET01359 0.521 0.008 DBMET00411 0.133 0.089 DBMET01360 0.466 0.013 DBMET01361 0.141 0.083 DBMET00926 0.25 0.047 DBMET01362 | DBMET00411 | |
| 0.208 | 0.013 | 0.37 | 5 Hydroxytryptamine 3A agonist | 0.132 0.047 DBMET00258 0.37 0.002 DBMET01359 0.24 0.006 DBMET00411 0.141 0.04 DBMET01360 0.283 0.004 DBMET01361 0.295 0.004 DBMET01362 | DBMET01359 | |
| 0.213 | 0.021 | 0.446 | Alpha 2b adrenoreceptor antagonist | 0.168 0.032 DBMET00258 0.34 0.007 DBMET01359 0.158 0.035 DBMET00411 0.446 0.004 DBMET01360 0.376 0.005 DBMET01361 0.445 0.004 DBMET01362 | DBMET01360 | |
| 0.246 | 0.054 | 0.401 | Peptidyltransferase inhibitor | 0.185 0.12 DBMET00258 0.293 0.027 DBMET00411 0.386 0.008 DBMET00762 0.169 0.148 DBMET01361 0.206 0.092 DBMET00926 0.401 0.007 DBMET00925 | DBMET00925 | |
| 0.194 | 0.004 | 0.614 | 5 Hydroxytryptamine 2A agonist | 0.135 0.007 DBMET00258 0.614 0.002 DBMET01359 0.155 0.005 DBMET00411 0.229 0.004 DBMET01360 0.313 0.003 DBMET01361 0.333 0.003 DBMET01362 | DBMET01359 | |
| 0.312 | 0.123 | 0.426 | 15-Lipoxygenase inhibitor | 0.296 0.134 DBMET00258 0.404 0.073 DBMET01359 0.392 0.078 DBMET00411 0.357 0.095 DBMET01360 0.426 0.063 DBMET01361 0.245 0.169 DBMET00926 0.304 0.129 DBMET01362 | DBMET01361 | |
| 0.197 | 0.008 | 0.553 | 5 Hydroxytryptamine 1B antagonist | 0.401 0.004 DBMET01359 0.113 0.019 DBMET00411 0.147 0.013 DBMET01360 0.402 0.004 DBMET01361 0.553 0.003 DBMET01362 | DBMET01362 | |
| 0.252 | 0.066 | 0.539 | Tyrosine 3 hydroxylase inhibitor | 0.235 0.084 DBMET00258 0.279 0.045 DBMET01359 0.356 0.015 DBMET00411 0.539 0.004 DBMET01360 0.315 0.026 DBMET01361 0.274 0.049 DBMET01362 | DBMET01360 | |
| 0.246 | 0.061 | 0.272 | Neuropeptide Y2 antagonist | 0.204 0.112 DBMET01359 0.272 0.036 DBMET00411 0.229 0.078 DBMET01361 0.242 0.064 DBMET01362 | DBMET00411 | |
| 0.182 | 0.004 | 0.242 | Beta 3 adrenoreceptor antagonist | 0.124 0.009 DBMET00258 0.12 0.01 DBMET01359 0.242 0.003 DBMET00411 0.093 0.017 DBMET01360 0.231 0.004 DBMET01361 0.099 0.015 DBMET00926 0.159 0.005 DBMET01362 | DBMET00411 | |
| 0.276 | 0.101 | 0.329 | Sodium/bile acid cotransporter inhibitor | 0.232 0.148 DBMET00258 0.329 0.054 DBMET00411 0.214 0.17 DBMET00763 0.241 0.138 DBMET00762 0.255 0.123 DBMET01361 0.28 0.098 DBMET00926 0.276 0.102 DBMET00925 | DBMET00411 | |
| 0.181 | 0.012 | 0.426 | Prolactin inhibitor | 0.168 0.016 DBMET00258 0.232 0.005 DBMET01359 0.259 0.004 DBMET00411 0.129 0.032 DBMET01360 0.426 0.002 DBMET01361 0.383 0.002 DBMET01362 | DBMET01361 | |
| 0.184 | 0.018 | 0.509 | 5 Hydroxytryptamine 1 antagonist | 0.439 0.005 DBMET01359 0.084 0.044 DBMET00411 0.236 0.014 DBMET01360 0.372 0.007 DBMET01361 0.509 0.005 DBMET01362 | DBMET01362 | |
| 0.191 | 0.027 | 0.268 | CF transmembrane conductance regulator agonist | 0.178 0.038 DBMET00258 0.253 0.006 DBMET01359 0.21 0.017 DBMET00411 0.268 0.005 DBMET01361 0.156 0.065 DBMET00925 0.25 0.006 DBMET01362 | DBMET01361 | |
| 0.184 | 0.025 | 0.49 | Cyclooxygenase 3 inhibitor | 0.108 0.091 DBMET00258 0.132 0.065 DBMET01359 0.183 0.026 DBMET00411 0.419 0.004 DBMET00762 0.125 0.072 DBMET01360 0.49 0.003 DBMET00925 | DBMET00925 | |
| 0.212 | 0.054 | 0.291 | Growth hormone agonist | 0.139 0.097 DBMET00258 0.291 0.034 DBMET01359 0.273 0.038 DBMET00411 0.19 0.063 DBMET01361 0.125 0.113 DBMET00926 0.125 0.113 DBMET00925 0.178 0.068 DBMET01362 | DBMET01359 | |
| 0.178 | 0.021 | 0.541 | 5 Hydroxytryptamine 2C antagonist | 0.411 0.005 DBMET01359 0.097 0.047 DBMET00411 0.541 0.004 DBMET01360 0.3 0.009 DBMET01361 0.467 0.005 DBMET01362 | DBMET01360 | |
| 0.16 | 0.004 | 0.567 | 5 Hydroxytryptamine 1B agonist | 0.092 0.008 DBMET00258 0.563 0.003 DBMET01359 0.156 0.004 DBMET00411 0.063 0.024 DBMET00763 0.087 0.01 DBMET01360 0.442 0.003 DBMET01361 0.106 0.006 DBMET00926 0.054 0.035 DBMET00925 0.567 0.003 DBMET01362 | DBMET01362 | |
| 0.178 | 0.028 | 0.236 | Adenylate cyclase stimulant | 0.183 0.024 DBMET00258 0.223 0.007 DBMET01359 0.223 0.007 DBMET00411 0.156 0.053 DBMET00763 0.143 0.076 DBMET00762 0.161 0.046 DBMET01360 0.236 0.005 DBMET01361 0.197 0.015 DBMET00926 0.162 0.044 DBMET00925 0.202 0.013 DBMET01362 | DBMET01361 | |
| 0.233 | 0.086 | 0.541 | Superoxide dismutase inhibitor | 0.244 0.078 DBMET00258 0.356 0.035 DBMET01359 0.258 0.07 DBMET00411 0.27 0.063 DBMET00763 0.541 0.01 DBMET01360 0.186 0.133 DBMET01361 0.301 0.05 DBMET00926 | DBMET01360 | |
| 0.153 | 0.007 | 0.663 | 5 Hydroxytryptamine 5 antagonist | 0.056 0.044 DBMET00258 0.532 0.003 DBMET01359 0.099 0.015 DBMET00411 0.406 0.003 DBMET01360 0.509 0.003 DBMET01361 0.663 0.002 DBMET01362 | DBMET01362 | |
| 0.167 | 0.026 | 0.345 | Alpha 2c adrenoreceptor antagonist | 0.118 0.051 DBMET00258 0.239 0.012 DBMET01359 0.131 0.042 DBMET00411 0.345 0.005 DBMET01360 0.259 0.009 DBMET01361 0.303 0.006 DBMET01362 | DBMET01360 | |
| 0.207 | 0.067 | 0.219 | Insulin sensitizer | 0.167 0.111 DBMET01359 0.219 0.056 DBMET00411 0.161 0.118 DBMET00762 0.181 0.094 DBMET01361 0.152 0.13 DBMET00926 0.213 0.061 DBMET00925 0.157 0.124 DBMET01362 | DBMET00411 | |
| 0.258 | 0.119 | 0.447 | Apoptosis antagonist | 0.212 0.164 DBMET00258 0.199 0.18 DBMET01359 0.299 0.086 DBMET00411 0.447 0.028 DBMET00762 0.236 0.142 DBMET01361 0.446 0.028 DBMET00925 | DBMET00762 | |
| 0.143 | 0.004 | 0.143 | Melatonin 3 antagonist | 0.028 0.009 DBMET01359 0.105 0.005 DBMET00411 0.028 0.009 DBMET00926 0.019 0.014 DBMET01362 | ||
| 0.235 | 0.097 | 0.304 | Gastrin inhibitor | 0.216 0.125 DBMET01359 0.238 0.094 DBMET00411 0.239 0.093 DBMET01361 0.197 0.154 DBMET00925 0.304 0.03 DBMET01362 | DBMET01362 | |
| 0.178 | 0.041 | 0.21 | Histone deacetylase SIRT1 inhibitor | 0.127 0.083 DBMET01359 0.21 0.027 DBMET00411 0.133 0.077 DBMET00926 0.11 0.105 DBMET00925 | DBMET00411 | |
| 0.162 | 0.025 | 0.182 | Heat shock protein 70 antagonist | 0.137 0.087 DBMET00258 0.156 0.034 DBMET01359 0.176 0.014 DBMET00411 0.163 0.024 DBMET00762 0.163 0.024 DBMET01361 0.182 0.011 DBMET00925 0.153 0.039 DBMET01362 | DBMET00925 | |
| 0.145 | 0.008 | 0.672 | 5 Hydroxytryptamine 5A antagonist | 0.062 0.042 DBMET00258 0.529 0.003 DBMET01359 0.107 0.014 DBMET00411 0.409 0.003 DBMET01360 0.539 0.003 DBMET01361 0.672 0.002 DBMET01362 | DBMET01362 | |
| 0.179 | 0.043 | 0.29 | Nav1.2 sodium channel blocker | 0.172 0.046 DBMET01359 0.149 0.058 DBMET00411 0.208 0.032 DBMET01361 0.159 0.052 DBMET00926 0.29 0.016 DBMET01362 | DBMET01362 | |
| 0.152 | 0.02 | 0.387 | 5 Hydroxytryptamine 1A antagonist | 0.375 0.006 DBMET01359 0.072 0.045 DBMET00411 0.201 0.014 DBMET01360 0.27 0.01 DBMET01361 0.387 0.006 DBMET01362 | DBMET01362 | |
| 0.255 | 0.124 | 0.707 | Transcription factor NF kappa B inhibitor | 0.237 0.137 DBMET00258 0.259 0.121 DBMET01359 0.313 0.088 DBMET00411 0.707 0.02 DBMET00762 0.301 0.094 DBMET01360 0.255 0.124 DBMET01361 0.645 0.026 DBMET00925 | DBMET00762 | |
| 0.187 | 0.062 | 0.279 | Tumour necrosis factor antagonist | 0.279 0.023 DBMET01359 0.213 0.046 DBMET01360 | DBMET01359 | |
| 0.212 | 0.088 | 0.519 | Free radical scavenger | 0.321 0.046 DBMET00258 0.211 0.089 DBMET01359 0.316 0.048 DBMET00411 0.16 0.134 DBMET00763 0.519 0.014 DBMET00762 0.28 0.057 DBMET01360 0.288 0.055 DBMET01361 0.175 0.119 DBMET00926 0.514 0.015 DBMET00925 | DBMET00762 | |
| 0.139 | 0.018 | 0.611 | 5 Hydroxytryptamine 1F antagonist | 0.289 0.006 DBMET01359 0.124 0.022 DBMET00411 0.117 0.025 DBMET01360 0.478 0.004 DBMET01361 0.611 0.004 DBMET01362 | DBMET01362 | |
| 0.125 | 0.005 | 0.418 | 5 Hydroxytryptamine 7 agonist | 0.076 0.015 DBMET00258 0.418 0.002 DBMET01359 0.083 0.011 DBMET00411 0.202 0.004 DBMET01360 0.304 0.003 DBMET01361 0.346 0.003 DBMET01362 | DBMET01359 | |
| 0.175 | 0.055 | 0.37 | Melanin inhibitor | 0.173 0.056 DBMET00258 0.18 0.051 DBMET01359 0.205 0.039 DBMET00411 0.337 0.017 DBMET00762 0.164 0.065 DBMET01361 0.37 0.014 DBMET00925 | DBMET00925 | |
| 0.209 | 0.09 | 0.646 | Angiogenesis stimulant | 0.182 0.104 DBMET00258 0.203 0.093 DBMET01359 0.265 0.063 DBMET00411 0.37 0.028 DBMET00763 0.609 0.006 DBMET00762 0.162 0.115 DBMET01361 0.428 0.018 DBMET00926 0.646 0.005 DBMET00925 | DBMET00925 | |
| 0.127 | 0.009 | 0.151 | Beta adrenoreceptor antagonist | 0.093 0.019 DBMET00258 0.105 0.014 DBMET01359 0.151 0.006 DBMET00411 0.075 0.032 DBMET01360 0.123 0.01 DBMET01361 0.09 0.021 DBMET01362 | DBMET00411 | |
| 0.132 | 0.02 | 0.216 | Adrenaline agonist | 0.12 0.025 DBMET00258 0.15 0.014 DBMET01359 0.216 0.005 DBMET00411 0.215 0.005 DBMET01361 0.144 0.016 DBMET01362 | DBMET00411 | |
| 0.118 | 0.008 | 0.199 | GABA B receptor agonist | 0.128 0.006 DBMET00258 0.199 0.003 DBMET01359 0.15 0.004 DBMET00411 0.07 0.069 DBMET00763 0.089 0.027 DBMET01360 0.135 0.005 DBMET01361 0.078 0.047 DBMET00926 0.115 0.009 DBMET01362 | DBMET01359 | |
| 0.153 | 0.045 | 0.162 | Proteasome inhibitor | 0.162 0.04 DBMET00411 | DBMET00411 | |
| 0.137 | 0.029 | 0.167 | Breast cancer-resistant protein inhibitor | 0.129 0.033 DBMET00258 0.14 0.028 DBMET01359 0.104 0.052 DBMET00411 0.153 0.023 DBMET00763 0.167 0.019 DBMET01360 0.086 0.07 DBMET01361 0.133 0.031 DBMET00926 | DBMET01360 | |
| 0.111 | 0.004 | 0.445 | 5 Hydroxytryptamine 1D agonist | 0.029 0.02 DBMET00258 0.251 0.002 DBMET01359 0.088 0.005 DBMET00411 0.088 0.005 DBMET01360 0.264 0.002 DBMET01361 0.445 0.001 DBMET01362 | DBMET01362 | |
| 0.117 | 0.013 | 0.124 | Bombesin 1 receptor agonist | 0.079 0.026 DBMET00258 0.124 0.012 DBMET01359 0.114 0.014 DBMET00411 0.055 0.047 DBMET00763 0.094 0.02 DBMET01360 0.1 0.018 DBMET01361 0.075 0.028 DBMET00926 0.119 0.013 DBMET01362 | DBMET01359 | |
| 0.109 | 0.007 | 0.611 | Cholecystokinin A antagonist | 0.103 0.008 DBMET00258 0.08 0.012 DBMET01359 0.119 0.006 DBMET00411 0.514 0.003 DBMET00763 0.097 0.009 DBMET01361 0.611 0.002 DBMET00926 0.198 0.005 DBMET01362 | DBMET00926 | |
| 0.108 | 0.008 | 0.136 | Histone deacetylase 7 inhibitor | 0.033 0.03 DBMET01359 0.115 0.007 DBMET00411 0.08 0.011 DBMET01361 0.136 0.005 DBMET01362 | DBMET01362 | |
| 0.109 | 0.009 | 0.131 | Beta 1 adrenoreceptor antagonist | 0.082 0.016 DBMET00258 0.097 0.011 DBMET01359 0.131 0.006 DBMET00411 0.067 0.029 DBMET01360 0.11 0.008 DBMET01361 0.087 0.014 DBMET01362 | DBMET00411 | |
| 0.145 | 0.051 | 0.566 | 5 Hydroxytryptamine antagonist | 0.419 0.01 DBMET01359 0.512 0.007 DBMET01360 0.342 0.015 DBMET01361 0.566 0.005 DBMET01362 | DBMET01362 | |
| 0.205 | 0.111 | 0.377 | DNA damaging | 0.215 0.104 DBMET00258 0.377 0.034 DBMET01359 0.211 0.107 DBMET00411 0.293 0.06 DBMET00762 0.293 0.06 DBMET01360 0.344 0.043 DBMET01361 0.236 0.089 DBMET00925 0.315 0.051 DBMET01362 | DBMET01359 | |
| 0.139 | 0.046 | 0.522 | 5 Hydroxytryptamine 2B antagonist | 0.372 0.01 DBMET01359 0.098 0.086 DBMET00411 0.522 0.005 DBMET01360 0.345 0.012 DBMET01361 0.474 0.005 DBMET01362 | DBMET01360 | |
| 0.135 | 0.042 | 0.216 | Photosensitizer | 0.114 0.065 DBMET00258 0.139 0.039 DBMET01359 0.147 0.033 DBMET00411 0.2 0.013 DBMET00762 0.125 0.051 DBMET01360 0.16 0.025 DBMET01361 0.216 0.01 DBMET00925 0.166 0.023 DBMET01362 | DBMET00925 | |
| 0.099 | 0.008 | 0.581 | Cholecystokinin antagonist | 0.081 0.011 DBMET00258 0.068 0.015 DBMET01359 0.115 0.007 DBMET00411 0.438 0.003 DBMET00763 0.09 0.009 DBMET01361 0.581 0.003 DBMET00926 0.203 0.005 DBMET01362 | DBMET00926 | |
| 0.116 | 0.025 | 0.168 | Somatostatin 1 agonist | 0.095 0.037 DBMET00258 0.154 0.013 DBMET01359 0.15 0.014 DBMET00411 0.073 0.06 DBMET00762 0.163 0.011 DBMET01361 0.096 0.037 DBMET00926 0.091 0.04 DBMET00925 0.168 0.01 DBMET01362 | DBMET01362 | |
| 0.22 | 0.13 | 0.296 | 12-Lipoxygenase inhibitor | 0.25 0.109 DBMET00258 0.296 0.082 DBMET00411 0.199 0.153 DBMET01361 | DBMET00411 | |
| 0.12 | 0.03 | 0.488 | Histamine N-methyltransferase inhibitor | 0.093 0.053 DBMET00258 0.323 0.003 DBMET01359 0.155 0.013 DBMET00411 0.456 0.002 DBMET01361 0.488 0.002 DBMET01362 | DBMET01362 | |
| 0.129 | 0.042 | 0.188 | Butyrylcholinesterase inhibitor | 0.111 0.053 DBMET01359 0.098 0.063 DBMET00411 0.174 0.027 DBMET01360 0.156 0.032 DBMET01361 0.188 0.024 DBMET01362 | DBMET01362 | |
| 0.125 | 0.041 | 0.21 | Carbonic anhydrase III inhibitor | 0.118 0.045 DBMET00258 0.12 0.045 DBMET01359 0.21 0.014 DBMET00411 0.099 0.063 DBMET00762 0.127 0.04 DBMET01360 0.18 0.02 DBMET01361 0.167 0.023 DBMET00926 0.113 0.05 DBMET00925 0.11 0.052 DBMET01362 | DBMET00411 | |
| 0.143 | 0.059 | 0.264 | NADPH oxidase inhibitor | 0.159 0.049 DBMET00258 0.264 0.018 DBMET01359 0.159 0.049 DBMET00411 0.165 0.046 DBMET00762 0.253 0.02 DBMET01360 0.239 0.023 DBMET01361 0.115 0.089 DBMET00925 0.162 0.048 DBMET01362 | DBMET01359 | |
| 0.134 | 0.051 | 0.504 | 5 Hydroxytryptamine 2 antagonist | 0.333 0.014 DBMET01359 0.504 0.006 DBMET01360 0.295 0.017 DBMET01361 0.449 0.008 DBMET01362 | DBMET01360 | |
| 0.137 | 0.055 | 0.159 | Histone deacetylase class III inhibitor | 0.159 0.037 DBMET00411 | DBMET00411 | |
| 0.108 | 0.026 | 0.189 | Glycine receptor antagonist | 0.093 0.04 DBMET00258 0.087 0.047 DBMET01359 0.134 0.012 DBMET00411 0.145 0.009 DBMET00763 0.174 0.004 DBMET00762 0.113 0.022 DBMET01360 0.142 0.009 DBMET01361 0.189 0.004 DBMET00926 0.187 0.004 DBMET00925 0.167 0.005 DBMET01362 | DBMET00926 | |
| 0.124 | 0.044 | 0.185 | Carbonic anhydrase XV inhibitor | 0.088 0.086 DBMET00258 0.185 0.021 DBMET01359 0.152 0.03 DBMET00411 0.129 0.04 DBMET01361 0.102 0.065 DBMET01362 | DBMET01359 | |
| 0.09 | 0.011 | 0.103 | Cyclin D1 inhibitor | 0.077 0.021 DBMET00258 0.103 0.007 DBMET01359 0.071 0.027 DBMET00411 0.09 0.011 DBMET01360 0.083 0.016 DBMET01361 0.093 0.01 DBMET01362 | DBMET01359 | |
| 0.141 | 0.063 | 0.219 | Tubulin antagonist | 0.209 0.034 DBMET00258 0.162 0.052 DBMET01359 0.137 0.065 DBMET00763 0.219 0.032 DBMET01360 | DBMET01360 | |
| 0.121 | 0.044 | 0.15 | Falcipain inhibitor | 0.124 0.042 DBMET00411 0.119 0.045 DBMET00762 0.078 0.077 DBMET01361 0.15 0.031 DBMET00925 0.083 0.07 DBMET01362 | DBMET00925 | |
| 0.086 | 0.01 | 0.135 | Beta 2 adrenoreceptor antagonist | 0.07 0.017 DBMET00258 0.068 0.018 DBMET01359 0.135 0.005 DBMET00411 0.052 0.033 DBMET01360 0.098 0.008 DBMET01361 0.045 0.044 DBMET00926 0.07 0.016 DBMET01362 | DBMET00411 | |
| 0.081 | 0.004 | 0.089 | Bombesin 1 receptor antagonist | 0.05 0.013 DBMET00258 0.074 0.005 DBMET01359 0.086 0.004 DBMET00411 0.036 0.027 DBMET00763 0.037 0.026 DBMET00762 0.067 0.005 DBMET01361 0.06 0.008 DBMET00926 0.042 0.02 DBMET00925 0.089 0.004 DBMET01362 | DBMET01362 | |
| 0.124 | 0.049 | 0.254 | Protein kinase C gamma inhibitor | 0.113 0.058 DBMET00258 0.217 0.011 DBMET01359 0.16 0.026 DBMET00411 0.226 0.01 DBMET01360 0.254 0.006 DBMET01361 0.249 0.007 DBMET01362 | DBMET01361 | |
| 0.12 | 0.045 | 0.12 | Bronchodilator | 0.098 0.066 DBMET00258 0.11 0.053 DBMET01359 0.116 0.047 DBMET00411 0.119 0.045 DBMET00762 0.097 0.067 DBMET01361 | ||
| 0.104 | 0.031 | 0.121 | Histamine H2 receptor antagonist | 0.105 0.03 DBMET01359 0.086 0.053 DBMET00411 0.088 0.051 DBMET01361 0.121 0.02 DBMET01362 | DBMET01362 | |
| 0.079 | 0.008 | 0.094 | Histamine H2 receptor agonist | 0.089 0.005 DBMET01359 0.073 0.009 DBMET00411 0.052 0.02 DBMET01361 0.094 0.004 DBMET01362 | DBMET01362 | |
| 0.191 | 0.121 | 0.545 | Antioxidant | 0.29 0.065 DBMET00258 0.172 0.14 DBMET01359 0.284 0.068 DBMET00411 0.306 0.059 DBMET00763 0.545 0.015 DBMET00762 0.16 0.153 DBMET01360 0.259 0.079 DBMET01361 0.312 0.057 DBMET00926 0.545 0.016 DBMET00925 | DBMET00925 | |
| 0.098 | 0.028 | 0.139 | Estrogen-related receptor beta agonist | 0.08 0.069 DBMET00258 0.08 0.067 DBMET01359 0.122 0.009 DBMET00411 0.139 0.005 DBMET01361 0.103 0.021 DBMET01362 | DBMET01361 | |
| 0.078 | 0.008 | 0.133 | Histone deacetylase 9 inhibitor | 0.036 0.034 DBMET01359 0.101 0.006 DBMET00411 0.07 0.009 DBMET01361 0.133 0.005 DBMET01362 | DBMET01362 | |
| 0.129 | 0.06 | 0.29 | Adenylate cyclase inhibitor | 0.189 0.028 DBMET01359 0.204 0.025 DBMET00411 0.29 0.014 DBMET01361 0.136 0.055 DBMET00925 0.253 0.019 DBMET01362 | DBMET01361 | |
| 0.113 | 0.045 | 0.144 | Falcipain 2 inhibitor | 0.116 0.044 DBMET00411 0.113 0.045 DBMET00762 0.076 0.075 DBMET01361 0.144 0.031 DBMET00925 0.081 0.068 DBMET01362 | DBMET00925 | |
| 0.09 | 0.023 | 0.091 | Histone deacetylase inhibitor | 0.089 0.024 DBMET00411 0.061 0.053 DBMET01361 0.091 0.022 DBMET01362 | DBMET01362 | |
| 0.107 | 0.041 | 0.172 | Toll-Like receptor 3 antagonist | 0.172 0.009 DBMET01359 0.122 0.028 DBMET01360 0.085 0.081 DBMET01361 0.1 0.051 DBMET01362 | DBMET01359 | |
| 0.074 | 0.009 | 0.078 | Immunoglobulin Fc receptor antagonist | 0.053 0.045 DBMET00258 0.073 0.009 DBMET01359 0.078 0.007 DBMET00411 0.069 0.012 DBMET01361 0.076 0.008 DBMET01362 | DBMET00411 | |
| 0.189 | 0.127 | 0.57 | Immunostimulant | 0.173 0.137 DBMET01359 0.304 0.077 DBMET00411 0.167 0.141 DBMET00763 0.506 0.028 DBMET00762 0.221 0.109 DBMET01361 0.36 0.061 DBMET00926 0.57 0.02 DBMET00925 0.183 0.131 DBMET01362 | DBMET00925 | |
| 0.09 | 0.028 | 0.109 | Sirtuin 1 inhibitor | 0.072 0.042 DBMET01359 0.109 0.018 DBMET00411 | DBMET00411 | |
| 0.095 | 0.035 | 0.095 | Metalloproteinase-9 inhibitor | 0.066 0.064 DBMET01359 0.088 0.039 DBMET00411 | ||
| 0.065 | 0.005 | 0.065 | Follicle-stimulating hormone agonist | 0.025 0.012 DBMET00258 0.057 0.005 DBMET01359 0.051 0.005 DBMET00411 0.024 0.013 DBMET00763 0.045 0.007 DBMET01361 0.046 0.007 DBMET00926 0.062 0.005 DBMET01362 | ||
| 0.178 | 0.119 | 0.2 | ErbB-1 antagonist | 0.2 0.089 DBMET00258 0.159 0.156 DBMET01359 0.169 0.135 DBMET00411 0.168 0.137 DBMET01360 0.183 0.11 DBMET01361 | DBMET00258 | |
| 0.152 | 0.093 | 0.157 | Cyclin-dependent kinase 3 inhibitor | 0.156 0.083 DBMET00411 0.157 0.082 DBMET01360 0.136 0.135 DBMET01361 | DBMET01360 | |
| 0.167 | 0.108 | 0.213 | Growth factor agonist | 0.16 0.12 DBMET01359 0.173 0.097 DBMET00411 0.198 0.065 DBMET01361 0.213 0.052 DBMET01362 | DBMET01362 | |
| 0.133 | 0.076 | 0.26 | Nav1.6 sodium channel blocker | 0.167 0.038 DBMET01359 0.123 0.091 DBMET01360 0.199 0.019 DBMET01361 0.26 0.009 DBMET01362 | DBMET01362 | |
| 0.113 | 0.056 | 0.242 | MAO A inhibitor | 0.129 0.048 DBMET01359 0.123 0.051 DBMET00411 0.242 0.022 DBMET01360 0.227 0.024 DBMET01361 0.157 0.039 DBMET01362 | DBMET01360 | |
| 0.125 | 0.069 | 0.19 | Nav1.3 sodium channel blocker | 0.125 0.069 DBMET01361 0.19 0.028 DBMET01362 | DBMET01362 | |
| 0.108 | 0.052 | 0.307 | GABA C receptor rho-1 antagonist | 0.121 0.039 DBMET00258 0.209 0.007 DBMET01359 0.146 0.023 DBMET00411 0.307 0.003 DBMET01360 0.166 0.015 DBMET01361 0.192 0.009 DBMET01362 | DBMET01360 | |
| 0.101 | 0.046 | 0.43 | 5 Hydroxytryptamine 2A antagonist | 0.282 0.012 DBMET01359 0.43 0.006 DBMET01360 0.242 0.015 DBMET01361 0.394 0.007 DBMET01362 | DBMET01360 | |
| 0.067 | 0.012 | 0.104 | Growth hormone secretagogue receptor antagonist | 0.104 0.006 DBMET01359 0.05 0.018 DBMET00411 0.035 0.024 DBMET01361 0.098 0.007 DBMET01362 | DBMET01359 | |
| 0.109 | 0.055 | 0.147 | Gastric antisecretory | 0.095 0.073 DBMET00763 0.109 0.055 DBMET01361 0.135 0.034 DBMET00926 0.147 0.028 DBMET01362 | DBMET01362 | |
| 0.068 | 0.014 | 0.073 | Bombesin antagonist | 0.05 0.029 DBMET00258 0.063 0.016 DBMET01359 0.073 0.011 DBMET00411 0.044 0.041 DBMET00762 0.059 0.019 DBMET01361 0.058 0.02 DBMET00926 0.045 0.039 DBMET00925 0.07 0.013 DBMET01362 | DBMET00411 | |
| 0.072 | 0.019 | 0.088 | Bombesin 2 receptor antagonist | 0.046 0.04 DBMET00258 0.078 0.018 DBMET01359 0.088 0.015 DBMET00411 0.048 0.036 DBMET01360 0.061 0.023 DBMET01361 0.047 0.039 DBMET00926 0.07 0.019 DBMET01362 | DBMET00411 | |
| 0.124 | 0.074 | 0.16 | Acetylcholinesterase inhibitor | 0.12 0.078 DBMET01359 0.152 0.054 DBMET01360 0.16 0.049 DBMET01361 0.16 0.049 DBMET01362 | DBMET01362 | |
| 0.062 | 0.012 | 0.074 | Benzodiazepine antagonist | 0.045 0.04 DBMET01359 0.045 0.038 DBMET01360 0.046 0.035 DBMET01361 0.074 0.006 DBMET01362 | DBMET01362 | |
| 0.064 | 0.015 | 0.112 | Adenylate cyclase 1 inhibitor | 0.076 0.009 DBMET01359 0.073 0.011 DBMET00411 0.104 0.004 DBMET01361 0.112 0.004 DBMET01362 | DBMET01362 | |
| 0.069 | 0.02 | 0.091 | Beta 2 adrenoreceptor agonist | 0.066 0.028 DBMET00258 0.071 0.018 DBMET01359 0.091 0.005 DBMET00411 0.086 0.006 DBMET01361 0.06 0.049 DBMET00926 0.07 0.018 DBMET01362 | DBMET00411 | |
| 0.111 | 0.062 | 0.17 | Nav1.4 sodium channel blocker | 0.147 0.035 DBMET01359 0.141 0.038 DBMET00411 0.131 0.043 DBMET00763 0.154 0.032 DBMET01361 0.17 0.027 DBMET00926 0.153 0.032 DBMET01362 | DBMET00926 | |
| 0.08 | 0.032 | 0.081 | Neutrophil collagenase inhibitor | 0.057 0.055 DBMET01359 0.081 0.031 DBMET00411 0.059 0.051 DBMET01361 0.069 0.041 DBMET01362 | DBMET00411 | |
| 0.054 | 0.006 | 0.062 | GHS receptor antagonist | 0.057 0.005 DBMET01359 0.046 0.009 DBMET00411 0.031 0.025 DBMET01360 0.038 0.014 DBMET01361 0.033 0.021 DBMET00926 0.062 0.005 DBMET01362 | DBMET01362 | |
| 0.068 | 0.02 | 0.111 | Ryanodine receptor antagonist | 0.069 0.019 DBMET01359 0.111 0.004 DBMET01360 | DBMET01360 | |
| 0.068 | 0.021 | 0.313 | 5 Hydroxytryptamine 2 agonist | 0.282 0.003 DBMET01359 0.045 0.044 DBMET00411 0.313 0.003 DBMET01360 0.157 0.005 DBMET01361 0.251 0.004 DBMET01362 | DBMET01360 | |
| 0.069 | 0.022 | 0.335 | 5 Hydroxytryptamine 1A agonist | 0.233 0.008 DBMET01359 0.044 0.034 DBMET00411 0.335 0.005 DBMET01360 0.098 0.016 DBMET01361 0.241 0.007 DBMET01362 | DBMET01360 | |
| 0.126 | 0.079 | 0.337 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.337 0.012 DBMET01359 0.147 0.067 DBMET00411 0.24 0.034 DBMET01361 0.321 0.014 DBMET01362 | DBMET01359 | |
| 0.087 | 0.041 | 0.194 | Alpha 1b adrenoreceptor antagonist | 0.172 0.018 DBMET01359 0.185 0.016 DBMET01360 0.15 0.022 DBMET01361 0.194 0.015 DBMET01362 | DBMET01362 | |
| 0.13 | 0.084 | 0.189 | Vascular endothelial growth factor 3 antagonist | 0.189 0.046 DBMET01359 0.141 0.074 DBMET01360 | DBMET01359 | |
| 0.07 | 0.025 | 0.087 | Gonadotropin-releasing hormone receptor agonist | 0.055 0.052 DBMET00258 0.067 0.029 DBMET01359 0.075 0.021 DBMET00411 0.083 0.016 DBMET01361 0.087 0.014 DBMET01362 | DBMET01362 | |
| 0.12 | 0.075 | 0.12 | Cathepsin H inhibitor | 0.119 0.077 DBMET00411 | ||
| 0.081 | 0.036 | 0.081 | Amidase inhibitor | 0.075 0.042 DBMET00411 0.063 0.061 DBMET01361 0.063 0.06 DBMET01362 | ||
| 0.11 | 0.066 | 0.178 | GABA receptor agonist | 0.166 0.028 DBMET01359 0.107 0.069 DBMET00411 0.093 0.086 DBMET01360 0.131 0.048 DBMET01361 0.178 0.024 DBMET01362 | DBMET01362 | |
| 0.092 | 0.047 | 0.113 | Granulocyte macrophage colony stimulating factor agonist | 0.109 0.024 DBMET00258 0.107 0.027 DBMET01359 0.113 0.021 DBMET01360 | DBMET01360 | |
| 0.091 | 0.047 | 0.097 | Factor XII inhibitor | 0.097 0.04 DBMET01359 0.086 0.055 DBMET00411 0.081 0.065 DBMET01362 | DBMET01359 | |
| 0.07 | 0.027 | 0.09 | Histone deacetylase SIRT3 inhibitor | 0.062 0.043 DBMET01359 0.09 0.013 DBMET00411 0.062 0.043 DBMET01362 | DBMET00411 | |
| 0.059 | 0.017 | 0.065 | Melanocortin 1 antagonist | 0.044 0.022 DBMET01359 0.065 0.016 DBMET00411 0.05 0.02 DBMET01362 | DBMET00411 | |
| 0.086 | 0.047 | 0.09 | Metalloproteinase-2 inhibitor | 0.09 0.044 DBMET00411 | DBMET00411 | |
| 0.125 | 0.087 | 0.189 | Neurotrophic factor | 0.114 0.105 DBMET00258 0.148 0.061 DBMET01359 0.137 0.072 DBMET00411 0.121 0.093 DBMET00762 0.18 0.038 DBMET01361 0.127 0.084 DBMET00925 0.189 0.033 DBMET01362 | DBMET01362 | |
| 0.055 | 0.016 | 0.098 | GHS receptor agonist | 0.087 0.005 DBMET01359 0.051 0.019 DBMET00411 0.067 0.01 DBMET01361 0.098 0.005 DBMET01362 | DBMET01362 | |
| 0.048 | 0.01 | 0.536 | Cholecystokinin B antagonist | 0.044 0.012 DBMET00258 0.033 0.019 DBMET01359 0.062 0.008 DBMET00411 0.41 0.003 DBMET00763 0.048 0.011 DBMET01361 0.536 0.003 DBMET00926 0.129 0.005 DBMET01362 | DBMET00926 | |
| 0.188 | 0.152 | 0.197 | Transcription factor STAT3 inhibitor | 0.197 0.138 DBMET00411 | DBMET00411 | |
| 0.132 | 0.097 | 0.153 | Phospholipase A2 inhibitor | 0.146 0.079 DBMET01359 0.153 0.071 DBMET00411 0.132 0.097 DBMET00925 | DBMET00411 | |
| 0.147 | 0.113 | 0.246 | Death-associated protein kinase 2 inhibitor | 0.151 0.103 DBMET00258 0.181 0.053 DBMET01359 0.175 0.06 DBMET00411 0.246 0.014 DBMET01360 0.164 0.078 DBMET01361 0.156 0.093 DBMET01362 | DBMET01360 | |
| 0.194 | 0.159 | 0.305 | Hypoxia-inducible factor 1 alpha inhibitor | 0.183 0.175 DBMET00258 0.207 0.144 DBMET01359 0.206 0.144 DBMET00411 0.212 0.138 DBMET00762 0.212 0.138 DBMET01360 0.305 0.063 DBMET01361 0.232 0.117 DBMET00925 0.228 0.12 DBMET01362 | DBMET01361 | |
| 0.05 | 0.018 | 0.076 | Beta adrenoreceptor agonist | 0.047 0.025 DBMET00258 0.05 0.018 DBMET01359 0.076 0.005 DBMET00411 0.067 0.006 DBMET01361 0.05 0.019 DBMET01362 | DBMET00411 | |
| 0.053 | 0.02 | 0.053 | Histone deacetylase 8 inhibitor | 0.052 0.02 DBMET00411 0.046 0.024 DBMET01362 | ||
| 0.058 | 0.025 | 0.058 | Metalloproteinase-3 inhibitor | 0.043 0.042 DBMET00411 0.05 0.033 DBMET00926 | ||
| 0.049 | 0.017 | 0.074 | Gonadotropin-releasing hormone receptor antagonist | 0.053 0.015 DBMET00411 0.045 0.018 DBMET01361 0.074 0.011 DBMET01362 | DBMET01362 | |
| 0.052 | 0.02 | 0.066 | Growth hormone release inhibitor | 0.039 0.033 DBMET00258 0.066 0.013 DBMET01359 0.064 0.014 DBMET00411 0.055 0.018 DBMET01361 0.04 0.032 DBMET00926 0.041 0.031 DBMET00925 0.059 0.016 DBMET01362 | DBMET01359 | |
| 0.036 | 0.004 | 0.042 | Follicle-stimulating hormone antagonist | 0.023 0.008 DBMET00258 0.036 0.004 DBMET01359 0.032 0.005 DBMET00411 0.026 0.005 DBMET00763 0.03 0.005 DBMET01361 0.037 0.004 DBMET00926 0.042 0.004 DBMET01362 | DBMET01362 | |
| 0.051 | 0.02 | 0.08 | Somatostatin 1 antagonist | 0.037 0.028 DBMET00258 0.08 0.009 DBMET01359 0.066 0.013 DBMET00411 0.069 0.012 DBMET01361 0.033 0.032 DBMET00926 0.038 0.028 DBMET00925 0.078 0.009 DBMET01362 | DBMET01359 | |
| 0.092 | 0.061 | 0.302 | Antiadrenergic | 0.125 0.043 DBMET01359 0.076 0.075 DBMET00411 0.302 0.013 DBMET01360 0.144 0.038 DBMET01361 0.167 0.031 DBMET01362 | DBMET01360 | |
| 0.046 | 0.015 | 0.086 | Somatostatin 5 agonist | 0.086 0.006 DBMET01359 0.052 0.012 DBMET00411 0.047 0.014 DBMET01360 0.042 0.017 DBMET01361 0.052 0.011 DBMET01362 | DBMET01359 | |
| 0.055 | 0.024 | 0.061 | Melanocortin antagonist | 0.061 0.02 DBMET01359 0.056 0.024 DBMET00411 0.055 0.025 DBMET01362 | DBMET01359 | |
| 0.095 | 0.065 | 0.133 | Sphingomyelinase inhibitor | 0.1 0.059 DBMET01361 0.133 0.033 DBMET01362 | DBMET01362 | |
| 0.109 | 0.079 | 0.164 | Interleukin 8 antagonist | 0.109 0.078 DBMET00258 0.123 0.057 DBMET01359 0.163 0.027 DBMET00411 0.119 0.063 DBMET01360 0.164 0.026 DBMET01361 0.149 0.034 DBMET01362 | DBMET01361 | |
| 0.09 | 0.06 | 0.287 | Adrenaline antagonist | 0.119 0.044 DBMET01359 0.287 0.014 DBMET01360 0.139 0.038 DBMET01361 0.162 0.032 DBMET01362 | DBMET01360 | |
| 0.052 | 0.022 | 0.053 | Melanocortin 4 antagonist | 0.053 0.022 DBMET01359 0.052 0.022 DBMET00411 0.046 0.026 DBMET01362 | DBMET01359 | |
| 0.069 | 0.039 | 0.099 | Aryl hydrocarbon receptor antagonist | 0.058 0.057 DBMET00258 0.09 0.019 DBMET01359 0.061 0.051 DBMET00411 0.086 0.021 DBMET01360 0.084 0.023 DBMET01361 0.099 0.014 DBMET01362 | DBMET01362 | |
| 0.066 | 0.037 | 0.149 | Alpha 1d adrenoreceptor antagonist | 0.126 0.018 DBMET01359 0.125 0.018 DBMET01360 0.1 0.023 DBMET01361 0.149 0.014 DBMET01362 | DBMET01362 | |
| 0.146 | 0.117 | 0.182 | Catenin beta inhibitor | 0.168 0.069 DBMET00411 0.182 0.049 DBMET01360 0.154 0.096 DBMET01361 | DBMET01360 | |
| 0.098 | 0.069 | 0.128 | Urease inhibitor | 0.119 0.046 DBMET00258 0.125 0.04 DBMET01359 0.117 0.048 DBMET00411 0.128 0.037 DBMET01361 0.11 0.055 DBMET01362 | DBMET01361 | |
| 0.045 | 0.018 | 0.145 | Somatostatin 4 agonist | 0.054 0.014 DBMET01359 0.068 0.01 DBMET00411 0.092 0.007 DBMET01361 0.145 0.005 DBMET01362 | DBMET01362 | |
| 0.086 | 0.059 | 0.195 | Antineoplastic alkaloid | 0.131 0.034 DBMET00258 0.094 0.052 DBMET01359 0.115 0.04 DBMET00411 0.195 0.015 DBMET01360 0.195 0.015 DBMET01361 0.174 0.021 DBMET01362 | DBMET01361 | |
| 0.069 | 0.042 | 0.07 | Potassium channel (ATP-sensitive) blocker | 0.063 0.055 DBMET01361 0.07 0.041 DBMET01362 | DBMET01362 | |
| 0.076 | 0.049 | 0.08 | Histone deacetylase SIRT2 inhibitor | 0.08 0.045 DBMET00411 | DBMET00411 | |
| 0.048 | 0.022 | 0.048 | Acetyl-CoA carboxylase inhibitor | 0.039 0.033 DBMET00411 | ||
| 0.059 | 0.033 | 0.059 | Matrix metalloproteinase (membrane-type) inhibitor | 0.051 0.044 DBMET00411 | ||
| 0.063 | 0.037 | 0.089 | Carbonic anhydrase stimulant | 0.089 0.022 DBMET01359 0.076 0.028 DBMET00411 0.063 0.037 DBMET01362 | DBMET01359 | |
| 0.118 | 0.093 | 0.155 | Vanilloid 1 agonist | 0.112 0.108 DBMET01359 0.12 0.088 DBMET00411 0.121 0.086 DBMET00762 0.155 0.034 DBMET01360 0.114 0.104 DBMET01361 | DBMET01360 | |
| 0.044 | 0.02 | 0.758 | Cholecystokinin B agonist | 0.043 0.021 DBMET01359 0.053 0.014 DBMET00411 0.591 0.002 DBMET00763 0.048 0.017 DBMET01361 0.758 0.001 DBMET00926 0.059 0.012 DBMET01362 | DBMET00926 | |
| 0.045 | 0.022 | 0.051 | Histone deacetylase class I inhibitor | 0.042 0.025 DBMET00411 0.051 0.019 DBMET01362 | DBMET01362 | |
| 0.061 | 0.038 | 0.061 | Cathepsin L inhibitor | 0.06 0.039 DBMET00411 | ||
| 0.104 | 0.081 | 0.209 | TRPA1 agonist | 0.124 0.054 DBMET01359 0.123 0.055 DBMET00411 0.209 0.009 DBMET01360 0.117 0.062 DBMET01361 0.097 0.093 DBMET00926 0.102 0.084 DBMET01362 | DBMET01360 | |
| 0.128 | 0.105 | 0.128 | Neuropeptide Y1 antagonist | 0.121 0.12 DBMET01359 0.126 0.108 DBMET00411 | ||
| 0.069 | 0.047 | 0.265 | Phenylalanine 4-hydroxylase inhibitor | 0.141 0.013 DBMET00258 0.207 0.006 DBMET01359 0.265 0.004 DBMET00411 0.242 0.005 DBMET01361 0.082 0.036 DBMET00926 0.175 0.009 DBMET01362 | DBMET00411 | |
| 0.031 | 0.009 | 0.795 | Cholecystokinin agonist | 0.022 0.012 DBMET01359 0.026 0.01 DBMET00411 0.612 0.002 DBMET00763 0.016 0.015 DBMET01361 0.795 0.001 DBMET00926 0.031 0.009 DBMET01362 | DBMET00926 | |
| 0.104 | 0.084 | 0.175 | Beta amyloid protein antagonist | 0.175 0.026 DBMET01359 0.101 0.089 DBMET00762 | DBMET01359 | |
| 0.196 | 0.176 | 0.318 | Caspase 3 stimulant | 0.318 0.07 DBMET00258 0.206 0.16 DBMET01359 0.278 0.091 DBMET00762 0.192 0.182 DBMET01361 0.242 0.12 DBMET00925 | DBMET00258 | |
| 0.048 | 0.028 | 0.069 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 DBMET00411 0.064 0.01 DBMET00762 0.069 0.008 DBMET00925 | DBMET00925 | |
| 0.064 | 0.044 | 0.081 | Calcium channel P-type blocker | 0.081 0.014 DBMET01359 0.062 0.049 DBMET01360 0.066 0.038 DBMET01361 0.08 0.014 DBMET01362 | DBMET01359 | |
| 0.038 | 0.019 | 0.043 | Sirtuin 2 inhibitor | 0.029 0.026 DBMET01359 0.043 0.015 DBMET00411 | DBMET00411 | |
| 0.049 | 0.031 | 0.057 | Endothelin-converting enzyme inhibitor | 0.045 0.034 DBMET01359 0.057 0.026 DBMET00411 0.04 0.038 DBMET01361 0.057 0.026 DBMET01362 | DBMET01362 | |
| 0.054 | 0.036 | 0.165 | GABA A receptor antagonist | 0.075 0.024 DBMET01359 0.054 0.036 DBMET00411 0.165 0.007 DBMET01360 0.054 0.036 DBMET01361 0.08 0.022 DBMET01362 | DBMET01360 | |
| 0.072 | 0.055 | 0.518 | Alpha 2a adrenoreceptor antagonist | 0.104 0.035 DBMET00258 0.213 0.012 DBMET01359 0.518 0.004 DBMET01360 0.213 0.012 DBMET01361 0.232 0.01 DBMET01362 | DBMET01360 | |
| 0.035 | 0.019 | 0.135 | Somatostatin agonist | 0.098 0.008 DBMET01359 0.057 0.012 DBMET00411 0.086 0.009 DBMET01361 0.135 0.006 DBMET01362 | DBMET01362 | |
| 0.054 | 0.038 | 0.183 | GABA receptor antagonist | 0.09 0.018 DBMET01359 0.057 0.034 DBMET00411 0.183 0.007 DBMET01360 0.055 0.037 DBMET01361 0.077 0.023 DBMET01362 | DBMET01360 | |
| 0.247 | 0.232 | 0.34 | 5 Hydroxytryptamine release inhibitor | 0.34 0.124 DBMET01359 0.277 0.192 DBMET00411 0.287 0.18 DBMET00762 0.316 0.147 DBMET01360 0.261 0.213 DBMET01361 0.337 0.127 DBMET00925 | DBMET01359 | |
| 0.064 | 0.049 | 0.064 | Matrix metalloproteinase inhibitor | |||
| 0.022 | 0.008 | 0.775 | Cholecystokinin A agonist | 0.019 0.009 DBMET01359 0.019 0.009 DBMET00411 0.467 0.002 DBMET00763 0.014 0.013 DBMET01361 0.775 0.001 DBMET00926 0.02 0.008 DBMET01362 | DBMET00926 | |
| 0.042 | 0.028 | 0.069 | Toll-Like receptor 2 agonist | 0.069 0.018 DBMET00411 0.041 0.029 DBMET00762 0.067 0.019 DBMET00925 0.035 0.034 DBMET01362 | DBMET00411 | |
| 0.071 | 0.058 | 0.221 | Alpha 1 adrenoreceptor antagonist | 0.136 0.032 DBMET01359 0.221 0.018 DBMET01360 0.123 0.036 DBMET01361 0.174 0.025 DBMET01362 | DBMET01360 | |
| 0.082 | 0.068 | 0.1 | Hematopoietic | 0.1 0.035 DBMET00411 0.084 0.062 DBMET01361 0.088 0.054 DBMET01362 | DBMET00411 | |
| 0.055 | 0.042 | 0.244 | 5 Hydroxytryptamine 6 antagonist | 0.156 0.005 DBMET01359 0.147 0.006 DBMET01360 0.148 0.006 DBMET01361 0.244 0.003 DBMET01362 | DBMET01362 | |
| 0.096 | 0.083 | 0.153 | Mucolytic | 0.1 0.077 DBMET00411 0.153 0.03 DBMET00762 0.106 0.07 DBMET00925 | DBMET00762 | |
| 0.096 | 0.084 | 0.16 | DOPA decarboxylase inhibitor | 0.138 0.029 DBMET00258 0.141 0.026 DBMET01359 0.159 0.017 DBMET00411 0.16 0.016 DBMET01361 0.107 0.063 DBMET01362 | DBMET01361 | |
| 0.098 | 0.086 | 0.098 | Electron transport complex I inhibitor | |||
| 0.06 | 0.048 | 0.261 | 5 Hydroxytryptamine 3 agonist | 0.165 0.004 DBMET01359 0.081 0.026 DBMET00411 0.06 0.049 DBMET01360 0.19 0.004 DBMET01361 0.261 0.003 DBMET01362 | DBMET01362 | |
| 0.188 | 0.177 | 0.328 | 5 Hydroxytryptamine uptake stimulant | 0.223 0.113 DBMET00258 0.27 0.064 DBMET01359 0.204 0.144 DBMET00411 0.328 0.033 DBMET01360 0.223 0.112 DBMET01361 0.229 0.104 DBMET01362 | DBMET01360 | |
| 0.145 | 0.135 | 0.265 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.219 0.064 DBMET01359 0.164 0.111 DBMET00411 0.196 0.079 DBMET01360 0.204 0.073 DBMET01361 0.265 0.046 DBMET01362 | DBMET01362 | |
| 0.034 | 0.024 | 0.038 | Benzodiazepine receptor peripheral-type antagonist | 0.038 0.017 DBMET01362 | DBMET01362 | |
| 0.092 | 0.082 | 0.393 | AMP-activated protein kinase stimulant | 0.125 0.044 DBMET00258 0.098 0.073 DBMET01359 0.129 0.042 DBMET00411 0.287 0.005 DBMET00762 0.137 0.036 DBMET01361 0.393 0.004 DBMET00925 0.107 0.062 DBMET01362 | DBMET00925 | |
| 0.049 | 0.039 | 0.049 | Matrix metalloproteinase 1 inhibitor | |||
| 0.025 | 0.016 | 0.028 | 5 Hydroxytryptamine 4 agonist | 0.028 0.009 DBMET01359 0.027 0.011 DBMET01362 | DBMET01359 | |
| 0.137 | 0.128 | 0.373 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.373 0.022 DBMET01359 0.161 0.102 DBMET00411 0.286 0.047 DBMET01361 0.362 0.025 DBMET01362 | DBMET01359 | |
| 0.08 | 0.071 | 0.442 | Alpha adrenoreceptor antagonist | 0.195 0.028 DBMET01359 0.442 0.008 DBMET01360 0.178 0.031 DBMET01361 0.227 0.023 DBMET01362 | DBMET01360 | |
| 0.023 | 0.014 | 0.026 | Bombesin agonist | 0.024 0.012 DBMET00411 0.026 0.01 DBMET01362 | DBMET01362 | |
| 0.049 | 0.04 | 0.091 | 5 Hydroxytryptamine 4 antagonist | 0.086 0.01 DBMET01359 0.048 0.042 DBMET01360 0.061 0.023 DBMET01361 0.091 0.009 DBMET01362 | DBMET01362 | |
| 0.157 | 0.149 | 0.473 | Tumour necrosis factor alpha release inhibitor | 0.16 0.146 DBMET01359 0.473 0.017 DBMET00762 0.261 0.07 DBMET01360 0.175 0.13 DBMET01361 0.345 0.039 DBMET00925 | DBMET00762 | |
| 0.037 | 0.03 | 0.101 | Substance P antagonist | 0.04 0.027 DBMET01359 0.047 0.019 DBMET01361 0.101 0.005 DBMET01362 | DBMET01362 | |
| 0.178 | 0.171 | 0.211 | Transcription factor STAT inhibitor | 0.211 0.122 DBMET00411 | DBMET00411 | |
| 0.031 | 0.023 | 0.067 | Somatostatin 5 antagonist | 0.067 0.009 DBMET01359 0.043 0.016 DBMET00411 0.042 0.017 DBMET01361 0.048 0.014 DBMET01362 | DBMET01359 | |
| 0.073 | 0.066 | 0.125 | Carbonic anhydrase VI inhibitor | 0.125 0.028 DBMET01359 0.119 0.03 DBMET00411 0.083 0.053 DBMET01360 0.102 0.038 DBMET01361 0.097 0.041 DBMET00926 | DBMET01359 | |
| 0.023 | 0.016 | 0.035 | Beta 1 adrenoreceptor agonist | 0.022 0.016 DBMET00258 0.026 0.011 DBMET01359 0.035 0.006 DBMET00411 0.029 0.009 DBMET01361 | DBMET00411 | |
| 0.037 | 0.03 | 0.037 | Cathepsin L1 inhibitor | |||
| 0.093 | 0.087 | 0.157 | Chelator | 0.096 0.084 DBMET00258 0.157 0.033 DBMET00411 0.153 0.034 DBMET01361 0.092 0.09 DBMET00925 0.095 0.084 DBMET01362 | DBMET00411 | |
| 0.028 | 0.022 | 0.19 | 5 Hydroxytryptamine 6 agonist | 0.108 0.002 DBMET01359 0.027 0.025 DBMET00411 0.035 0.011 DBMET01360 0.116 0.002 DBMET01361 0.19 0.001 DBMET01362 | DBMET01362 | |
| 0.085 | 0.08 | 0.101 | Interleukin 1 beta converting enzyme inhibitor | 0.101 0.056 DBMET00411 | DBMET00411 | |
| 0.09 | 0.087 | 0.159 | Adenylate kinase inhibitor | 0.091 0.086 DBMET00258 0.115 0.048 DBMET01359 0.13 0.036 DBMET00411 0.137 0.032 DBMET01361 0.092 0.083 DBMET00926 0.105 0.06 DBMET00925 0.159 0.023 DBMET01362 | DBMET01362 | |
| 0.054 | 0.051 | 0.121 | Dopamine D3 antagonist | 0.062 0.043 DBMET01359 0.107 0.023 DBMET01360 0.091 0.028 DBMET01361 0.121 0.02 DBMET01362 | DBMET01362 | |
| 0.018 | 0.015 | 0.021 | Bombesin 3 receptor agonist | 0.019 0.013 DBMET00411 0.021 0.01 DBMET01362 | DBMET01362 | |
| 0.12 | 0.117 | 0.255 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.229 0.052 DBMET01359 0.134 0.102 DBMET00411 0.137 0.099 DBMET01360 0.192 0.068 DBMET01361 0.255 0.044 DBMET01362 | DBMET01362 | |
| 0.024 | 0.022 | 0.067 | Somatostatin 2 antagonist | 0.067 0.01 DBMET01359 0.051 0.015 DBMET00411 0.048 0.016 DBMET01361 0.06 0.012 DBMET01362 | DBMET01359 | |
| 0.029 | 0.027 | 0.075 | Growth hormone releasing factor agonist | 0.037 0.02 DBMET01359 0.03 0.027 DBMET00411 0.035 0.021 DBMET01361 0.075 0.006 DBMET01362 | DBMET01362 | |
| 0.029 | 0.026 | 0.029 | Histone deacetylase 5 inhibitor | 0.029 0.026 DBMET01362 | ||
| 0.055 | 0.053 | 0.236 | Dopamine D2 antagonist | 0.096 0.034 DBMET01359 0.236 0.014 DBMET01360 0.143 0.024 DBMET01361 0.159 0.021 DBMET01362 | DBMET01360 | |
| 0.087 | 0.086 | 0.329 | Monophenol monooxygenase inhibitor | 0.153 0.046 DBMET00411 0.328 0.015 DBMET00762 0.329 0.015 DBMET00925 | DBMET00925 | |
| 0.018 | 0.016 | 0.027 | Somatostatin 3 agonist | 0.023 0.007 DBMET01359 0.019 0.012 DBMET00411 0.021 0.008 DBMET01361 0.027 0.005 DBMET01362 | DBMET01362 | |
| 0.116 | 0.115 | 0.316 | Thrombolytic | 0.139 0.091 DBMET01359 0.153 0.079 DBMET00411 0.14 0.09 DBMET00763 0.302 0.024 DBMET00762 0.283 0.027 DBMET01360 0.118 0.112 DBMET01361 0.224 0.042 DBMET00926 0.316 0.021 DBMET00925 | DBMET00925 | |
| 0.108 | 0.108 | 0.135 | Interleukin 1 antagonist | 0.11 0.105 DBMET01359 0.121 0.087 DBMET01361 0.135 0.07 DBMET01362 | DBMET01362 | |
| 0.021 | 0.02 | 0.036 | Somatostatin 4 antagonist | 0.036 0.01 DBMET01359 0.028 0.013 DBMET00411 0.026 0.014 DBMET01361 0.031 0.011 DBMET01362 | DBMET01359 | |
| 0.023 | 0.023 | 0.03 | Melanocortin 3 antagonist | 0.03 0.02 DBMET00411 0.026 0.022 DBMET01362 | DBMET00411 | |
| 0.059 | 0.059 | 0.083 | Prolactin release inhibitor | 0.06 0.051 DBMET00258 0.067 0.029 DBMET01359 0.066 0.032 DBMET00411 0.08 0.011 DBMET01361 0.083 0.009 DBMET01362 | DBMET01362 | |
| 0.026 | 0.026 | 0.041 | Peptide deformylase inhibitor | 0.028 0.024 DBMET00411 0.041 0.014 DBMET01362 | DBMET01362 | |
| 0.023 | 0.024 | 0.075 | Urotensin II agonist | 0.03 0.015 DBMET01359 0.027 0.018 DBMET00411 0.066 0.004 DBMET01361 0.075 0.004 DBMET01362 | DBMET01362 | |
| 0.05 | 0.051 | 0.13 | Alpha 1 adrenoreceptor agonist | 0.13 0.011 DBMET01359 0.064 0.032 DBMET01360 0.07 0.028 DBMET01361 0.093 0.019 DBMET01362 | DBMET01359 | |
| 0.023 | 0.024 | 0.045 | Thyroid hormone agonist | 0.045 0.005 DBMET00411 0.027 0.017 DBMET01361 0.045 0.005 DBMET00926 | DBMET00926 | |
| 0.094 | 0.095 | 0.102 | CDC-like kinase 3 inhibitor | 0.097 0.087 DBMET00258 0.102 0.075 DBMET01359 | DBMET01359 | |
| 0.073 | 0.075 | 0.462 | Alpha 2 adrenoreceptor antagonist | 0.094 0.052 DBMET00258 0.206 0.017 DBMET01359 0.462 0.004 DBMET01360 0.211 0.016 DBMET01361 0.246 0.012 DBMET01362 | DBMET01360 | |
| 0.086 | 0.088 | 0.136 | Phosphodiesterase 6D inhibitor | 0.094 0.064 DBMET00411 0.121 0.024 DBMET00762 0.119 0.026 DBMET01360 0.119 0.026 DBMET01361 0.136 0.014 DBMET00925 0.117 0.028 DBMET01362 | DBMET00925 | |
| 0.035 | 0.037 | 0.137 | 5 Hydroxytryptamine 2B agonist | 0.137 0.003 DBMET01359 0.091 0.004 DBMET01360 0.051 0.013 DBMET01361 0.085 0.005 DBMET01362 | DBMET01359 | |
| 0.036 | 0.038 | 0.121 | Dopamine D2 agonist | 0.038 0.036 DBMET00258 0.066 0.018 DBMET01359 0.06 0.021 DBMET00411 0.078 0.015 DBMET00763 0.121 0.008 DBMET01361 0.111 0.009 DBMET00926 0.104 0.01 DBMET01362 | DBMET01361 | |
| 0.107 | 0.11 | 0.142 | CDC-like kinase 1 inhibitor | 0.142 0.076 DBMET01359 0.112 0.104 DBMET01360 0.111 0.105 DBMET01361 | DBMET01359 | |
| 0.052 | 0.055 | 0.064 | Glucagon-like peptide 1 agonist | 0.061 0.047 DBMET01359 0.064 0.045 DBMET00411 | DBMET00411 | |
| 0.076 | 0.079 | 0.121 | CC chemokine 5 receptor agonist | 0.077 0.075 DBMET01359 0.107 0.015 DBMET00411 0.09 0.037 DBMET01360 0.121 0.008 DBMET01361 0.094 0.03 DBMET00926 0.103 0.018 DBMET01362 | DBMET01361 | |
| 0.06 | 0.063 | 0.245 | Dopamine antagonist | 0.097 0.04 DBMET01359 0.245 0.015 DBMET01360 0.153 0.025 DBMET01361 0.169 0.023 DBMET01362 | DBMET01360 | |
| 0.018 | 0.022 | 0.026 | Growth hormone releasing factor antagonist | 0.026 0.015 DBMET00411 | DBMET00411 | |
| 0.077 | 0.081 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.067 DBMET00411 | DBMET00411 | |
| 0.014 | 0.019 | 0.062 | Growth hormone release promoting | 0.017 0.016 DBMET01359 0.018 0.015 DBMET01361 0.062 0.005 DBMET01362 | DBMET01362 | |
| 0.016 | 0.02 | 0.033 | Somatostatin 3 antagonist | 0.03 0.009 DBMET01359 0.02 0.014 DBMET00411 0.033 0.009 DBMET01360 0.02 0.014 DBMET01361 0.028 0.01 DBMET01362 | DBMET01360 | |
| 0.024 | 0.029 | 0.032 | Histone deacetylase class IV inhibitor | 0.027 0.026 DBMET00411 0.032 0.021 DBMET01362 | DBMET01362 | |
| 0.024 | 0.029 | 0.032 | Histone deacetylase 11 inhibitor | 0.027 0.026 DBMET00411 0.032 0.021 DBMET01362 | DBMET01362 | |
| 0.073 | 0.078 | 0.114 | GABA A receptor agonist | 0.088 0.051 DBMET01359 0.076 0.072 DBMET01360 0.081 0.061 DBMET01361 0.114 0.027 DBMET01362 | DBMET01362 | |
| 0.017 | 0.023 | 0.113 | Dopamine autoreceptor agonist | 0.047 0.008 DBMET01359 0.022 0.018 DBMET00411 0.113 0.004 DBMET01361 0.092 0.004 DBMET01362 | DBMET01361 | |
| 0.016 | 0.022 | 0.021 | Melanocortin 1 agonist | 0.021 0.019 DBMET00411 | DBMET00411 | |
| 0.046 | 0.053 | 0.128 | Vanilloid 2 antagonist | 0.128 0.004 DBMET00258 0.048 0.047 DBMET00411 0.092 0.006 DBMET00763 0.049 0.045 DBMET01361 | DBMET00258 | |
| 0.045 | 0.052 | 0.091 | Beta tubulin antagonist | 0.091 0.025 DBMET00258 0.049 0.047 DBMET01360 | DBMET00258 | |
| 0.007 | 0.014 | 0.017 | Melatonin 5 antagonist | 0.017 0.005 DBMET01362 | DBMET01362 | |
| 0.08 | 0.087 | 0.256 | Protein kinase C zeta inhibitor | 0.106 0.044 DBMET00258 0.17 0.016 DBMET01359 0.107 0.043 DBMET00411 0.134 0.025 DBMET00763 0.173 0.015 DBMET01360 0.256 0.007 DBMET01361 0.131 0.026 DBMET00926 0.19 0.013 DBMET01362 | DBMET01361 | |
| 0.02 | 0.027 | 0.024 | ICAM 1 antagonist | 0.024 0.013 DBMET00411 0.022 0.018 DBMET01362 | DBMET00411 | |
| 0.104 | 0.111 | 0.27 | Lipid peroxidase inhibitor | 0.148 0.07 DBMET00258 0.17 0.055 DBMET00411 0.262 0.025 DBMET00762 0.131 0.082 DBMET01360 0.19 0.046 DBMET01361 0.115 0.099 DBMET00926 0.27 0.023 DBMET00925 | DBMET00925 | |
| 0.066 | 0.074 | 0.101 | Platelet growth factor antagonist | 0.101 0.04 DBMET00258 0.076 0.061 DBMET01359 | DBMET00258 | |
| 0.007 | 0.015 | 0.019 | Beta 3 adrenoreceptor agonist | 0.019 0.005 DBMET00411 0.013 0.007 DBMET01361 | DBMET00411 | |
| 0.055 | 0.063 | 0.186 | Alpha 1a adrenoreceptor antagonist | 0.099 0.037 DBMET01359 0.186 0.018 DBMET01360 0.096 0.038 DBMET01361 0.14 0.025 DBMET01362 | DBMET01360 | |
| 0.117 | 0.126 | 0.128 | Thiol protease inhibitor | 0.128 0.101 DBMET00411 | DBMET00411 | |
| 0.02 | 0.029 | 0.031 | Histone deacetylase 10 inhibitor | 0.031 0.02 DBMET01362 | DBMET01362 | |
| 0.049 | 0.059 | 0.106 | Neuraminidase inhibitor | 0.077 0.028 DBMET00411 0.091 0.019 DBMET00762 0.09 0.019 DBMET00926 0.106 0.013 DBMET00925 | DBMET00925 | |
| 0.06 | 0.071 | 0.074 | Rho-associated kinase I inhibitor | 0.071 0.055 DBMET01359 0.074 0.052 DBMET01362 | DBMET01362 | |
| 0.017 | 0.029 | 0.021 | Glutaminyl-peptide cyclotransferase inhibitor | 0.021 0.017 DBMET01359 | DBMET01359 | |
| 0.021 | 0.034 | 0.044 | Growth hormone secretagogue receptor agonist | 0.044 0.02 DBMET01362 | DBMET01362 | |
| 0.11 | 0.123 | 0.186 | Cholinergic | 0.186 0.053 DBMET01360 0.149 0.077 DBMET01361 0.17 0.062 DBMET01362 | DBMET01360 | |
| 0.045 | 0.059 | 0.065 | Bombesin 3 receptor antagonist | 0.051 0.045 DBMET01359 0.051 0.045 DBMET00411 0.05 0.047 DBMET01361 0.065 0.028 DBMET01362 | DBMET01362 | |
| 0.055 | 0.069 | 0.116 | Neuraminidase (influenza) inhibitor | 0.075 0.03 DBMET00411 0.061 0.051 DBMET00763 0.094 0.018 DBMET00762 0.112 0.013 DBMET00926 0.116 0.013 DBMET00925 | DBMET00925 | |
| 0.039 | 0.054 | 0.118 | Neurokinin antagonist | 0.053 0.03 DBMET01361 0.118 0.008 DBMET01362 | DBMET01362 | |
| 0.126 | 0.141 | 0.178 | Pyruvate kinase inhibitor | 0.161 0.106 DBMET00258 0.176 0.096 DBMET01359 0.162 0.106 DBMET00411 0.178 0.094 DBMET01361 | DBMET01361 | |
| 0.064 | 0.079 | 0.135 | Macrophage migration inhibitory factor inhibitor | 0.135 0.02 DBMET00258 0.086 0.045 DBMET01359 0.09 0.042 DBMET00411 0.087 0.044 DBMET01361 | DBMET00258 | |
| 0.085 | 0.1 | 0.285 | Beta glucuronidase inhibitor | 0.13 0.037 DBMET00258 0.113 0.052 DBMET01359 0.115 0.051 DBMET00411 0.273 0.007 DBMET00762 0.132 0.035 DBMET01361 0.285 0.007 DBMET00925 0.096 0.076 DBMET01362 | DBMET00925 | |
| 0.04 | 0.056 | 0.076 | Protein kinase C epsilon inhibitor | 0.067 0.026 DBMET01359 0.047 0.045 DBMET00411 0.057 0.033 DBMET01361 0.076 0.021 DBMET01362 | DBMET01362 | |
| 0.12 | 0.136 | 0.239 | LIM domain kinase 1 inhibitor | 0.177 0.075 DBMET01359 0.129 0.122 DBMET00411 0.192 0.067 DBMET01361 0.239 0.044 DBMET01362 | DBMET01362 | |
| 0.044 | 0.062 | 0.151 | Nicotinic receptor alpha7 subunit antagonist | 0.083 0.016 DBMET01359 0.098 0.013 DBMET01361 0.151 0.006 DBMET01362 | DBMET01362 | |
| 0.004 | 0.022 | 0.01 | Thyroid hormone beta agonist | 0.01 0.005 DBMET00411 | DBMET00411 | |
| 0.017 | 0.036 | 0.024 | Melanocortin 5 antagonist | 0.024 0.02 DBMET01359 | DBMET01359 | |
| 0.035 | 0.055 | 0.052 | Neuropeptide agonist | 0.052 0.042 DBMET00411 | DBMET00411 | |
| 0.045 | 0.065 | 0.058 | Epithelial sodium channel blocker | 0.051 0.046 DBMET01359 0.053 0.041 DBMET01361 0.058 0.032 DBMET01362 | DBMET01362 | |
| 0.182 | 0.202 | 0.647 | Antithrombotic | 0.199 0.179 DBMET01359 0.226 0.148 DBMET00411 0.254 0.123 DBMET00763 0.614 0.015 DBMET00762 0.253 0.123 DBMET01361 0.408 0.047 DBMET00926 0.647 0.012 DBMET00925 0.226 0.148 DBMET01362 | DBMET00925 | |
| 0.015 | 0.036 | 0.081 | Sigma 2 receptor antagonist | 0.026 0.019 DBMET01359 0.07 0.006 DBMET01361 0.081 0.005 DBMET01362 | DBMET01362 | |
| 0.052 | 0.074 | 0.167 | Carbonic anhydrase VA inhibitor | 0.061 0.058 DBMET01359 0.068 0.048 DBMET00411 0.086 0.033 DBMET00763 0.167 0.008 DBMET00926 | DBMET00926 | |
| 0.11 | 0.132 | 0.121 | Aurora-C kinase inhibitor | 0.121 0.103 DBMET00411 | DBMET00411 | |
| 0.092 | 0.114 | 0.149 | Aldehyde dehydrogenase inhibitor | 0.113 0.079 DBMET01359 0.149 0.048 DBMET00411 0.147 0.049 DBMET01361 0.12 0.071 DBMET00925 0.107 0.087 DBMET01362 | DBMET00411 | |
| 0.046 | 0.068 | 0.147 | Dopamine agonist | 0.114 0.022 DBMET01359 0.068 0.046 DBMET00411 0.091 0.031 DBMET01360 0.147 0.015 DBMET01361 0.064 0.049 DBMET00926 0.129 0.018 DBMET01362 | DBMET01361 | |
| 0.009 | 0.031 | 0.022 | Somatostatin 2 agonist | 0.017 0.008 DBMET01359 0.019 0.007 DBMET01361 0.022 0.006 DBMET01362 | DBMET01362 | |
| 0.028 | 0.051 | 0.101 | Neurokinin 2 antagonist | 0.042 0.028 DBMET01361 0.101 0.01 DBMET01362 | DBMET01362 | |
| 0.049 | 0.073 | 0.155 | Neuronal nicotinic receptor antagonist | 0.097 0.025 DBMET01359 0.089 0.03 DBMET01360 0.123 0.017 DBMET01361 0.155 0.012 DBMET01362 | DBMET01362 | |
| 0.021 | 0.045 | 0.032 | Toll-Like receptor 4 agonist | 0.03 0.011 DBMET00763 0.032 0.009 DBMET00762 0.032 0.009 DBMET00926 0.031 0.01 DBMET00925 | DBMET00926 | |
| 0.072 | 0.096 | 0.127 | Aminoacyl-tRNA synthetase inhibitor | 0.127 0.027 DBMET01359 0.089 0.061 DBMET00411 0.081 0.076 DBMET00925 | DBMET01359 | |
| 0.034 | 0.06 | 0.05 | Dihydrofolate reductase inhibitor | 0.05 0.019 DBMET01359 | DBMET01359 | |
| 0.105 | 0.131 | 0.129 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.095 DBMET00258 0.129 0.062 DBMET00411 | DBMET00411 | |
| 0.145 | 0.172 | 0.167 | MAP kinase kinase 5 inhibitor | 0.155 0.133 DBMET01359 0.167 0.093 DBMET01362 | DBMET01362 | |
| 0.083 | 0.111 | 0.204 | MAO inhibitor | 0.204 0.039 DBMET01359 0.166 0.053 DBMET01360 0.183 0.046 DBMET01361 0.13 0.069 DBMET01362 | DBMET01359 | |
| 0.034 | 0.063 | 0.085 | Histamine H1 receptor agonist | 0.056 0.011 DBMET01359 0.05 0.018 DBMET01361 0.085 0.003 DBMET01362 | DBMET01362 | |
| 0.124 | 0.153 | 0.199 | I kappa B kinase epsilon inhibitor | 0.137 0.134 DBMET01359 0.199 0.072 DBMET01360 | DBMET01360 | |
| 0.04 | 0.069 | 0.328 | 5 Hydroxytryptamine uptake inhibitor | 0.117 0.021 DBMET01359 0.116 0.022 DBMET01360 0.183 0.013 DBMET01361 0.328 0.005 DBMET01362 | DBMET01362 | |
| 0.028 | 0.057 | 0.067 | Glutamate (mGluR1a) antagonist | 0.048 0.022 DBMET01360 0.067 0.012 DBMET01362 | DBMET01362 | |
| 0.136 | 0.166 | 0.316 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.294 0.041 DBMET01359 0.263 0.054 DBMET01361 0.316 0.034 DBMET01362 | DBMET01362 | |
| 0.073 | 0.102 | 0.225 | Mediator release inhibitor | 0.103 0.066 DBMET00411 0.202 0.014 DBMET00762 0.111 0.057 DBMET01361 0.225 0.012 DBMET00925 0.097 0.073 DBMET01362 | DBMET00925 | |
| 0.043 | 0.074 | 0.127 | Acetylcholine M5 receptor antagonist | 0.098 0.018 DBMET01361 0.127 0.011 DBMET01362 | DBMET01362 | |
| 0.012 | 0.044 | 0.029 | Estrogen-related receptor gamma agonist | 0.022 0.008 DBMET00411 0.029 0.004 DBMET01361 0.019 0.012 DBMET01362 | DBMET01361 | |
| 0.037 | 0.07 | 0.104 | Histamine agonist | 0.08 0.014 DBMET01359 0.053 0.036 DBMET01361 0.104 0.008 DBMET01362 | DBMET01362 | |
| 0.028 | 0.061 | 0.072 | Neurokinin 1 antagonist | 0.072 0.012 DBMET01362 | DBMET01362 | |
| 0.071 | 0.105 | 0.156 | Vanilloid agonist | 0.088 0.05 DBMET00258 0.078 0.076 DBMET00411 0.156 0.01 DBMET01360 | DBMET01360 | |
| 0.031 | 0.066 | 0.049 | AICAR transformylase inhibitor | 0.049 0.024 DBMET00411 0.042 0.034 DBMET00926 | DBMET00411 | |
| 0.023 | 0.057 | 0.046 | Carbonic anhydrase I stimulant | 0.046 0.019 DBMET01359 | DBMET01359 | |
| 0.04 | 0.075 | 0.339 | Selectin antagonist | 0.061 0.048 DBMET00411 0.123 0.022 DBMET00763 0.306 0.005 DBMET00762 0.205 0.011 DBMET00926 0.339 0.004 DBMET00925 | DBMET00925 | |
| 0.059 | 0.095 | 0.08 | Keratolytic | 0.077 0.053 DBMET00258 0.076 0.054 DBMET01359 0.08 0.048 DBMET00411 | DBMET00411 | |
| 0.117 | 0.153 | 0.195 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.195 0.08 DBMET01359 0.14 0.129 DBMET00411 0.166 0.105 DBMET01361 0.186 0.088 DBMET01362 | DBMET01359 | |
| 0.051 | 0.087 | 0.13 | Benzodiazepine agonist | 0.07 0.05 DBMET01360 0.066 0.057 DBMET01361 0.13 0.012 DBMET01362 | DBMET01362 | |
| 0.075 | 0.112 | 0.091 | Nav1.1 sodium channel blocker | 0.09 0.08 DBMET01361 0.091 0.078 DBMET01362 | DBMET01362 | |
| 0.066 | 0.103 | 0.098 | Platelet activating factor alpha antagonist | 0.098 0.061 DBMET00258 | DBMET00258 | |
| 0.08 | 0.117 | 0.386 | GABA C receptor antagonist | 0.107 0.068 DBMET00258 0.181 0.017 DBMET01359 0.139 0.037 DBMET00411 0.386 0.003 DBMET01360 0.209 0.011 DBMET01361 0.227 0.009 DBMET01362 | DBMET01360 | |
| 0.139 | 0.176 | 0.328 | Interleukin agonist | 0.197 0.124 DBMET00411 0.251 0.078 DBMET00762 0.328 0.036 DBMET00925 | DBMET00925 | |
| 0.139 | 0.176 | 0.4 | Spasmolytic | 0.237 0.097 DBMET01359 0.166 0.149 DBMET00411 0.293 0.073 DBMET00762 0.208 0.113 DBMET01360 0.4 0.04 DBMET01361 0.252 0.09 DBMET00925 0.359 0.05 DBMET01362 | DBMET01361 | |
| 0.191 | 0.229 | 0.519 | Alpha-glucosidase inhibitor | 0.242 0.192 DBMET00411 0.519 0.075 DBMET00762 0.493 0.083 DBMET00925 | DBMET00762 | |
| 0.032 | 0.07 | 0.079 | GABA B receptor antagonist | 0.079 0.006 DBMET01359 0.049 0.02 DBMET01360 0.056 0.015 DBMET01361 0.073 0.008 DBMET01362 | DBMET01359 | |
| 0.138 | 0.176 | 0.361 | Cyclic AMP phosphodiesterase inhibitor | 0.165 0.129 DBMET00258 0.331 0.031 DBMET00762 0.361 0.023 DBMET01360 0.287 0.047 DBMET01361 0.248 0.064 DBMET00925 0.255 0.061 DBMET01362 | DBMET01360 | |
| 0.046 | 0.085 | 0.157 | Alpha adrenoreceptor agonist | 0.157 0.015 DBMET01359 0.089 0.033 DBMET01360 0.128 0.02 DBMET01361 0.152 0.016 DBMET01362 | DBMET01359 | |
| 0.054 | 0.092 | 0.123 | Protein kinase B gamma inhibitor | 0.123 0.024 DBMET01359 0.078 0.048 DBMET01362 | DBMET01359 | |
| 0.034 | 0.073 | 0.072 | Alpha tubulin antagonist | 0.072 0.023 DBMET00258 0.048 0.044 DBMET01360 | DBMET00258 | |
| 0.076 | 0.114 | 0.121 | Interleukin 12 antagonist | 0.086 0.081 DBMET00258 0.09 0.073 DBMET01359 0.095 0.062 DBMET00411 0.121 0.028 DBMET00762 0.097 0.059 DBMET01361 0.116 0.033 DBMET00925 | DBMET00762 | |
| 0.215 | 0.254 | 0.509 | Apoptosis agonist | 0.29 0.18 DBMET00258 0.237 0.229 DBMET00411 0.509 0.071 DBMET00762 0.274 0.192 DBMET01360 0.318 0.16 DBMET01361 0.479 0.081 DBMET00925 | DBMET00762 | |
| 0.077 | 0.116 | 0.103 | Alpha 2d adrenoreceptor antagonist | 0.089 0.072 DBMET01360 0.088 0.076 DBMET01361 0.103 0.044 DBMET01362 | DBMET01362 | |
| 0.03 | 0.069 | 0.05 | Opioid mu receptor agonist | 0.05 0.029 DBMET00411 0.046 0.032 DBMET01361 | DBMET00411 | |
| 0.039 | 0.078 | 0.079 | Protein kinase C theta inhibitor | 0.071 0.022 DBMET01359 0.06 0.036 DBMET01361 0.079 0.015 DBMET01362 | DBMET01362 | |
| 0.073 | 0.113 | 0.166 | Nitric-oxide synthase inhibitor | 0.165 0.017 DBMET01359 0.095 0.068 DBMET01360 0.115 0.041 DBMET01361 0.166 0.017 DBMET01362 | DBMET01362 | |
| 0.041 | 0.081 | 0.064 | Alpha 1L adrenoreceptor antagonist | 0.064 0.017 DBMET01360 | DBMET01360 | |
| 0.071 | 0.111 | 0.356 | Expectorant | 0.356 0.006 DBMET00762 0.241 0.014 DBMET00925 | DBMET00762 | |
| 0.021 | 0.062 | 0.054 | Diamine oxidase inhibitor | 0.054 0.012 DBMET01359 0.049 0.015 DBMET01362 | DBMET01359 | |
| 0.015 | 0.055 | 0.035 | Nicotinic alpha4beta2 receptor agonist | 0.03 0.017 DBMET01359 0.034 0.013 DBMET01360 0.027 0.023 DBMET01361 0.035 0.012 DBMET01362 | DBMET01362 | |
| 0.043 | 0.084 | 0.22 | Carbonic anhydrase V inhibitor | 0.061 0.053 DBMET00411 0.113 0.023 DBMET00763 0.22 0.005 DBMET00926 | DBMET00926 | |
| 0.125 | 0.168 | 0.266 | Platelet aggregation inhibitor | 0.149 0.13 DBMET01359 0.266 0.045 DBMET01360 | DBMET01360 | |
| 0.02 | 0.064 | 0.223 | 5 Hydroxytryptamine 3B antagonist | 0.06 0.011 DBMET01359 0.083 0.006 DBMET01361 0.223 0.003 DBMET01362 | DBMET01362 | |
| 0.031 | 0.074 | 0.108 | Dopamine D4 antagonist | 0.059 0.042 DBMET01359 0.059 0.043 DBMET01360 0.073 0.035 DBMET01361 0.108 0.024 DBMET01362 | DBMET01362 | |
| 0.021 | 0.067 | 0.034 | Opioid delta receptor agonist | 0.033 0.028 DBMET00411 0.034 0.027 DBMET01361 | DBMET01361 | |
| 0.06 | 0.107 | 0.111 | Opioid antagonist | 0.109 0.042 DBMET00411 0.111 0.04 DBMET01361 | DBMET01361 | |
| 0.035 | 0.083 | 0.263 | 5 Hydroxytryptamine 7 antagonist | 0.161 0.017 DBMET01359 0.25 0.008 DBMET01360 0.155 0.017 DBMET01361 0.263 0.007 DBMET01362 | DBMET01362 | |
| 0.031 | 0.079 | 0.058 | Potassium channel small-conductance Ca-activated blocker | 0.051 0.024 DBMET01360 0.058 0.018 DBMET01362 | DBMET01362 | |
| 0.07 | 0.119 | 0.13 | Polo-like kinase-4 inhibitor | 0.095 0.082 DBMET01359 0.13 0.048 DBMET01360 0.108 0.069 DBMET01362 | DBMET01360 | |
| 0.052 | 0.101 | 0.141 | Calcium antagonist | 0.141 0.025 DBMET01362 | DBMET01362 | |
| 0.044 | 0.093 | 0.102 | Catalase inhibitor | 0.064 0.06 DBMET00411 0.07 0.055 DBMET00763 0.102 0.038 DBMET00926 | DBMET00926 | |
| 0.062 | 0.112 | 0.146 | Protein kinase C delta inhibitor | 0.14 0.026 DBMET01359 0.086 0.068 DBMET00411 0.129 0.032 DBMET01361 0.146 0.023 DBMET01362 | DBMET01362 | |
| 0.056 | 0.107 | 0.071 | MDM2 inhibitor | 0.071 0.036 DBMET01362 | DBMET01362 | |
| 0.053 | 0.104 | 0.173 | Acetylcholine nicotinic antagonist | 0.112 0.033 DBMET01359 0.097 0.042 DBMET01360 0.143 0.022 DBMET01361 0.173 0.016 DBMET01362 | DBMET01362 | |
| 0.082 | 0.134 | 0.286 | Alpha-N-acetylglucosaminidase inhibitor | 0.164 0.048 DBMET00411 0.173 0.044 DBMET00762 0.286 0.018 DBMET00925 | DBMET00925 | |
| 0.008 | 0.062 | 0.036 | Histamine H4 receptor agonist | 0.018 0.013 DBMET01359 0.036 0.005 DBMET01362 | DBMET01362 | |
| 0.09 | 0.144 | 0.124 | Transcription factor STAT6 inhibitor | 0.124 0.053 DBMET00411 0.119 0.061 DBMET01361 0.114 0.072 DBMET01362 | DBMET00411 | |
| 0.008 | 0.063 | 0.015 | Nicotinic alpha4 receptor agonist | 0.015 0.013 DBMET01360 0.015 0.014 DBMET01362 | DBMET01362 | |
| 0.048 | 0.104 | 0.076 | I kappa B kinase 1 inhibitor | 0.075 0.042 DBMET01359 0.076 0.04 DBMET01362 | DBMET01362 | |
| 0.067 | 0.124 | 0.085 | Polo-like kinase-1 inhibitor | 0.085 0.072 DBMET01362 | DBMET01362 | |
| 0.027 | 0.085 | 0.053 | Carbonic anhydrase XIV inhibitor | 0.053 0.03 DBMET00762 0.051 0.032 DBMET00925 | DBMET00762 | |
| 0.028 | 0.086 | 0.093 | Protein 50S ribosomal subunit inhibitor | 0.09 0.016 DBMET00762 0.093 0.015 DBMET00925 | DBMET00925 | |
| 0.094 | 0.152 | 0.235 | Acetylcholine M1 receptor antagonist | 0.143 0.081 DBMET01359 0.125 0.101 DBMET00411 0.117 0.114 DBMET01360 0.223 0.033 DBMET01361 0.235 0.029 DBMET01362 | DBMET01362 | |
| 0.037 | 0.096 | 0.114 | Nicotinic alpha3beta2 receptor antagonist | 0.114 0.005 DBMET01360 0.05 0.043 DBMET01361 0.078 0.014 DBMET01362 | DBMET01360 | |
| 0.042 | 0.101 | 0.065 | CDC25B inhibitor | 0.057 0.055 DBMET00411 0.065 0.043 DBMET01361 | DBMET01361 | |
| 0.016 | 0.076 | 0.027 | Acid ceramidase inhibitor | 0.027 0.014 DBMET01362 | DBMET01362 | |
| 0.036 | 0.096 | 0.088 | Opioid mu receptor antagonist | 0.088 0.036 DBMET00411 0.075 0.043 DBMET01361 | DBMET00411 | |
| 0.126 | 0.187 | 0.167 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.167 0.11 DBMET01359 0.145 0.142 DBMET01362 | DBMET01359 | |
| 0.033 | 0.094 | 0.092 | Protein kinase C eta inhibitor | 0.048 0.047 DBMET01359 0.048 0.047 DBMET00411 0.085 0.022 DBMET01360 0.092 0.019 DBMET01361 0.089 0.02 DBMET01362 | DBMET01361 | |
| 0.086 | 0.148 | 0.253 | Toll-Like receptor antagonist | 0.2 0.03 DBMET01359 0.253 0.014 DBMET01360 0.148 0.057 DBMET01361 0.153 0.054 DBMET01362 | DBMET01360 | |
| 0.06 | 0.122 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | 0.106 0.05 DBMET01359 0.089 0.066 DBMET00411 0.103 0.052 DBMET01360 0.081 0.077 DBMET01362 | DBMET01359 | |
| 0.064 | 0.126 | 0.117 | ATPase (Vacuolar H+) inhibitor | 0.117 0.022 DBMET00762 0.111 0.027 DBMET00925 | DBMET00762 | |
| 0.029 | 0.091 | 0.083 | Opioid delta receptor antagonist | 0.083 0.035 DBMET00411 0.065 0.043 DBMET01361 | DBMET00411 | |
| 0.068 | 0.131 | 0.111 | EphA2 antagonist | 0.111 0.064 DBMET00258 0.104 0.072 DBMET01359 0.096 0.079 DBMET00762 | DBMET00258 | |
| 0.014 | 0.078 | 0.039 | Dopamine D3 agonist | 0.039 0.028 DBMET01359 | DBMET01359 | |
| 0.099 | 0.163 | 0.245 | MAP3K9 inhibitor | 0.137 0.081 DBMET01359 0.245 0.005 DBMET01360 0.14 0.076 DBMET01361 0.14 0.076 DBMET01362 | DBMET01360 | |
| 0.077 | 0.141 | 0.114 | Bone formation stimulant | 0.114 0.091 DBMET00411 0.105 0.101 DBMET00925 | DBMET00411 | |
| 0.04 | 0.105 | 0.162 | Histidine decarboxylase inhibitor | 0.065 0.057 DBMET00258 0.162 0.018 DBMET01359 0.089 0.037 DBMET00411 0.073 0.048 DBMET01361 | DBMET01359 | |
| 0.023 | 0.088 | 0.118 | Carbonic anhydrase VB inhibitor | 0.053 0.041 DBMET00411 0.053 0.042 DBMET01361 0.118 0.013 DBMET00926 | DBMET00926 | |
| 0.067 | 0.131 | 0.212 | DNA intercalator | 0.17 0.035 DBMET00258 0.138 0.048 DBMET00763 0.122 0.056 DBMET00762 0.128 0.053 DBMET01360 0.202 0.025 DBMET01361 0.128 0.053 DBMET00925 0.212 0.023 DBMET01362 | DBMET01362 | |
| 0.047 | 0.112 | 0.229 | CYP2A6 inhibitor | 0.214 0.006 DBMET01359 0.136 0.02 DBMET01361 0.229 0.005 DBMET01362 | DBMET01362 | |
| 0.012 | 0.078 | 0.041 | Leukotriene A4 hydrolase inhibitor | 0.041 0.025 DBMET01359 | DBMET01359 | |
| 0.088 | 0.155 | 0.13 | Sphingosine 1-phosphate receptor 2 agonist | 0.13 0.041 DBMET01360 0.101 0.099 DBMET01361 | DBMET01360 | |
| 0.02 | 0.088 | 0.111 | NMDA 2A receptor antagonist | 0.066 0.026 DBMET01359 0.081 0.019 DBMET00411 0.111 0.011 DBMET01361 0.082 0.019 DBMET01362 | DBMET01361 | |
| 0.04 | 0.109 | 0.18 | Carbonic anhydrase XIII inhibitor | 0.078 0.051 DBMET01359 0.142 0.023 DBMET00763 0.074 0.055 DBMET00762 0.18 0.017 DBMET00926 | DBMET00926 | |
| 0.126 | 0.196 | 0.302 | Vasodilator | 0.302 0.047 DBMET00762 0.236 0.078 DBMET01360 0.22 0.09 DBMET01361 0.281 0.055 DBMET00925 0.181 0.121 DBMET01362 | DBMET00762 | |
| 0.115 | 0.185 | 0.156 | Death-associated protein kinase 3 inhibitor | 0.155 0.115 DBMET01359 0.149 0.124 DBMET01360 0.141 0.138 DBMET01361 0.156 0.113 DBMET01362 | DBMET01362 | |
| 0.012 | 0.084 | 0.112 | 5 Hydroxytryptamine 1F agonist | 0.053 0.005 DBMET01361 0.112 0.004 DBMET01362 | DBMET01362 | |
| 0.044 | 0.116 | 0.126 | Topoisomerase II alpha inhibitor | 0.125 0.028 DBMET00762 0.091 0.045 DBMET01361 0.126 0.028 DBMET00925 | DBMET00925 | |
| 0.031 | 0.104 | 0.074 | CXC chemokine 4 receptor antagonist | 0.057 0.044 DBMET01359 0.054 0.047 DBMET01361 0.074 0.034 DBMET01362 | DBMET01362 | |
| 0.108 | 0.181 | 0.245 | Antimitotic | 0.145 0.126 DBMET00258 0.235 0.066 DBMET01359 0.149 0.122 DBMET00763 0.245 0.061 DBMET01360 | DBMET01360 | |
| 0.037 | 0.11 | 0.059 | Fibroblast growth factor 2 antagonist | 0.059 0.053 DBMET01359 | DBMET01359 | |
| 0.051 | 0.125 | 0.096 | Phosphodiesterase VI inhibitor | 0.096 0.023 DBMET01360 | DBMET01360 | |
| 0.01 | 0.085 | 0.025 | Dopamine D1 agonist | 0.023 0.016 DBMET00763 0.025 0.012 DBMET01360 0.021 0.019 DBMET01361 0.023 0.015 DBMET00926 0.024 0.014 DBMET00925 | DBMET01360 | |
| 0.06 | 0.135 | 0.188 | Phosphodiesterase 11A inhibitor | 0.188 0.005 DBMET01360 | DBMET01360 | |
| 0.06 | 0.135 | 0.188 | Phosphodiesterase XI inhibitor | 0.188 0.005 DBMET01360 | DBMET01360 | |
| 0.114 | 0.191 | 0.247 | ATPase inhibitor | 0.247 0.014 DBMET00762 0.154 0.095 DBMET01361 0.238 0.017 DBMET00925 0.153 0.096 DBMET01362 | DBMET00762 | |
| 0.036 | 0.113 | 0.228 | Dopamine D1 antagonist | 0.07 0.04 DBMET01359 0.228 0.009 DBMET01360 0.157 0.014 DBMET01361 0.092 0.028 DBMET01362 | DBMET01360 | |
| 0.055 | 0.133 | 0.095 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.086 0.054 DBMET01359 0.095 0.043 DBMET01360 | DBMET01360 | |
| 0.106 | 0.186 | 0.157 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.14 0.092 DBMET01359 0.148 0.076 DBMET01361 0.157 0.061 DBMET01362 | DBMET01362 | |
| 0.039 | 0.119 | 0.055 | Heat shock protein 90 beta antagonist | 0.054 0.051 DBMET00411 0.055 0.048 DBMET01361 | DBMET01361 | |
| 0.178 | 0.258 | 0.644 | Antibacterial | 0.223 0.204 DBMET01359 0.293 0.141 DBMET00411 0.335 0.111 DBMET00763 0.635 0.015 DBMET00762 0.417 0.069 DBMET00926 0.644 0.014 DBMET00925 | DBMET00925 | |
| 0.153 | 0.234 | 0.358 | Angiogenesis inhibitor | 0.358 0.068 DBMET00763 0.253 0.121 DBMET00762 0.223 0.145 DBMET01360 0.319 0.083 DBMET00926 0.227 0.141 DBMET00925 | DBMET00763 | |
| 0.097 | 0.179 | 0.413 | Hemostatic | 0.144 0.075 DBMET01359 0.233 0.024 DBMET00763 0.36 0.01 DBMET00762 0.392 0.008 DBMET00926 0.413 0.007 DBMET00925 | DBMET00925 | |
| 0.074 | 0.155 | 0.106 | Nav1.5 sodium channel blocker | 0.106 0.075 DBMET01362 | DBMET01362 | |
| 0.051 | 0.133 | 0.154 | Aminopeptidase B inhibitor | 0.121 0.052 DBMET00411 0.083 0.079 DBMET01361 0.154 0.036 DBMET00926 0.092 0.071 DBMET01362 | DBMET00926 | |
| 0.081 | 0.163 | 0.151 | Protein kinase C nu inhibitor | 0.151 0.069 DBMET01359 0.11 0.106 DBMET01360 0.129 0.083 DBMET01362 | DBMET01359 | |
| 0.014 | 0.099 | 0.047 | TRPM8 blocker | 0.047 0.018 DBMET01359 0.041 0.023 DBMET01360 | DBMET01359 | |
| 0.033 | 0.117 | 0.052 | Carbonic anhydrase II stimulant | 0.052 0.036 DBMET01359 | DBMET01359 | |
| 0.038 | 0.123 | 0.139 | Acetylcholine M4 receptor antagonist | 0.092 0.035 DBMET01360 0.087 0.04 DBMET01361 0.139 0.012 DBMET01362 | DBMET01362 | |
| 0.005 | 0.091 | 0.041 | Sigma 1 receptor antagonist | 0.026 0.019 DBMET01361 0.041 0.012 DBMET01362 | DBMET01362 | |
| 0.093 | 0.18 | 0.145 | Clk dual-specificity kinase inhibitor | 0.145 0.119 DBMET01359 0.141 0.123 DBMET01362 | DBMET01359 | |
| 0.026 | 0.112 | 0.073 | Acetylcholine M2 receptor antagonist | 0.059 0.045 DBMET01361 0.073 0.034 DBMET01362 | DBMET01362 | |
| 0.167 | 0.254 | 0.403 | Interleukin 2 agonist | 0.259 0.109 DBMET00411 0.368 0.038 DBMET00762 0.403 0.027 DBMET00925 | DBMET00925 | |
| 0.004 | 0.091 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET00762 0.015 0.014 DBMET00925 | DBMET00762 | |
| 0.101 | 0.188 | 0.162 | MAP kinase kinase 2 inhibitor | 0.153 0.119 DBMET01359 0.153 0.118 DBMET01361 0.162 0.111 DBMET01362 | DBMET01362 | |
| 0.102 | 0.19 | 0.229 | Interferon gamma antagonist | 0.229 0.033 DBMET00762 0.213 0.037 DBMET00925 | DBMET00762 | |
| 0.072 | 0.16 | 0.192 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.192 0.054 DBMET01359 | DBMET01359 | |
| 0.052 | 0.141 | 0.081 | Viral attachment inhibitor | 0.081 0.048 DBMET01362 | DBMET01362 | |
| 0.032 | 0.123 | 0.133 | 5 Hydroxytryptamine 3A antagonist | 0.091 0.022 DBMET01359 0.065 0.048 DBMET01361 0.133 0.007 DBMET01362 | DBMET01362 | |
| 0.045 | 0.137 | 0.111 | Protein kinase A inhibitor | 0.111 0.039 DBMET01359 0.077 0.063 DBMET01360 0.074 0.066 DBMET01362 | DBMET01359 | |
| 0.021 | 0.113 | 0.037 | Protein kinase C beta I inhibitor | 0.033 0.024 DBMET01360 0.037 0.014 DBMET01361 0.037 0.014 DBMET01362 | DBMET01362 | |
| 0.105 | 0.198 | 0.59 | Aldehyde oxidase inhibitor | 0.238 0.087 DBMET00258 0.227 0.092 DBMET01359 0.185 0.113 DBMET00411 0.362 0.053 DBMET01360 0.59 0.02 DBMET01361 0.33 0.059 DBMET01362 | DBMET01361 | |
| 0.051 | 0.144 | 0.134 | Inducible nitric-oxide synthase inhibitor | 0.134 0.02 DBMET01359 0.094 0.042 DBMET01360 0.088 0.05 DBMET01362 | DBMET01359 | |
| 0.037 | 0.132 | 0.075 | Potassium channel (Ca-activated) blocker | 0.075 0.022 DBMET01360 | DBMET01360 | |
| 0.047 | 0.142 | 0.083 | Interferon agonist | 0.071 0.068 DBMET01361 0.079 0.053 DBMET00925 0.083 0.048 DBMET01362 | DBMET01362 | |
| 0.108 | 0.204 | 0.166 | MAP kinase kinase 4 inhibitor | 0.137 0.092 DBMET01359 0.139 0.086 DBMET00411 0.166 0.037 DBMET01360 0.156 0.052 DBMET01361 0.127 0.125 DBMET01362 | DBMET01360 | |
| 0.109 | 0.205 | 0.229 | Focal adhesion kinase 2 inhibitor | 0.157 0.12 DBMET01359 0.229 0.049 DBMET01360 0.195 0.073 DBMET01362 | DBMET01360 | |
| 0.048 | 0.147 | 0.192 | Topoisomerase I inhibitor | 0.107 0.065 DBMET01359 0.192 0.029 DBMET00762 0.144 0.044 DBMET01360 0.178 0.032 DBMET01361 0.189 0.029 DBMET00925 0.104 0.066 DBMET01362 | DBMET00762 | |
| 0.044 | 0.143 | 0.153 | NMDA receptor antagonist | 0.095 0.05 DBMET01359 0.131 0.031 DBMET00411 0.088 0.056 DBMET01360 0.153 0.023 DBMET01361 0.108 0.042 DBMET00926 0.097 0.049 DBMET01362 | DBMET01361 | |
| 0.131 | 0.23 | 0.183 | Lipoxygenase inhibitor | 0.183 0.16 DBMET00258 | DBMET00258 | |
| 0.126 | 0.225 | 0.211 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.129 DBMET00258 0.203 0.069 DBMET01359 0.211 0.064 DBMET01361 0.167 0.112 DBMET01362 | DBMET01361 | |
| 0.01 | 0.111 | 0.041 | Kainate receptor 2 antagonist | 0.035 0.026 DBMET01360 0.041 0.021 DBMET01362 | DBMET01362 | |
| 0.041 | 0.142 | 0.064 | Interferon inducer | 0.064 0.045 DBMET00925 0.062 0.049 DBMET01362 | DBMET00925 | |
| 0.072 | 0.174 | 0.352 | Toll-Like receptor 9 antagonist | 0.352 0.006 DBMET01360 0.133 0.075 DBMET01361 0.171 0.05 DBMET01362 | DBMET01360 | |
| 0.039 | 0.143 | 0.09 | Analgesic, opioid | 0.072 0.059 DBMET00411 0.09 0.038 DBMET01361 | DBMET01361 | |
| 0.076 | 0.181 | 0.124 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.124 0.102 DBMET01359 | DBMET01359 | |
| 0.026 | 0.13 | 0.09 | Acetylcholine M5 receptor agonist | 0.09 0.026 DBMET01360 | DBMET01360 | |
| 0.051 | 0.157 | 0.155 | Protein kinase C mu inhibitor | 0.155 0.024 DBMET01360 0.086 0.073 DBMET01361 0.1 0.057 DBMET01362 | DBMET01360 | |
| 0.004 | 0.111 | 0.031 | AMPA 1 receptor antagonist | 0.031 0.02 DBMET00411 0.029 0.021 DBMET01362 | DBMET00411 | |
| 0.092 | 0.199 | 0.315 | Nitric oxide antagonist | 0.315 0.038 DBMET00762 0.302 0.04 DBMET00925 | DBMET00762 | |
| 0.055 | 0.162 | 0.084 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.084 0.075 DBMET00925 | DBMET00925 | |
| 0.028 | 0.136 | 0.094 | Alpha 2 adrenoreceptor agonist | 0.078 0.025 DBMET01359 0.068 0.034 DBMET01360 0.076 0.026 DBMET01361 0.094 0.017 DBMET01362 | DBMET01362 | |
| 0.058 | 0.165 | 0.103 | Thioredoxin inhibitor | 0.096 0.053 DBMET00762 0.103 0.045 DBMET00925 | DBMET00925 | |
| 0.047 | 0.156 | 0.079 | Opioid kappa receptor antagonist | 0.077 0.062 DBMET00411 0.079 0.059 DBMET01361 | DBMET01361 | |
| 0.078 | 0.187 | 0.198 | Protein kinase stimulant | 0.151 0.068 DBMET01359 0.198 0.042 DBMET00762 0.182 0.049 DBMET00925 | DBMET00762 | |
| 0.048 | 0.157 | 0.158 | Protein-tyrosine phosphatase 1B inhibitor | 0.099 0.079 DBMET00763 0.091 0.088 DBMET00762 0.158 0.042 DBMET00926 0.11 0.07 DBMET00925 | DBMET00926 | |
| 0.01 | 0.12 | 0.326 | 5 Hydroxytryptamine 2C agonist | 0.064 0.018 DBMET01359 0.326 0.003 DBMET01360 0.048 0.029 DBMET01362 | DBMET01360 | |
| 0.016 | 0.126 | 0.067 | Dopamine D5 agonist | 0.062 0.011 DBMET01359 0.048 0.019 DBMET00411 0.067 0.009 DBMET01360 0.065 0.01 DBMET01361 | DBMET01360 | |
| 0.028 | 0.139 | 0.062 | Nitric oxide donor | 0.062 0.044 DBMET00762 0.062 0.044 DBMET00925 | DBMET00925 | |
| 0.018 | 0.129 | 0.047 | Opioid agonist | 0.047 0.043 DBMET01361 | DBMET01361 | |
| 0.037 | 0.148 | 0.092 | Protein kinase B alpha inhibitor | 0.075 0.044 DBMET01359 0.092 0.034 DBMET01362 | DBMET01362 | |
| 0.055 | 0.167 | 0.105 | MAP kinase kinase 7 inhibitor | 0.086 0.033 DBMET01359 0.087 0.03 DBMET00411 0.105 0.009 DBMET01360 0.103 0.01 DBMET01361 0.076 0.058 DBMET01362 | DBMET01360 | |
| 0.064 | 0.176 | 0.111 | Microtubule formation inhibitor | 0.111 0.072 DBMET00762 0.105 0.081 DBMET01360 | DBMET00762 | |
| 0.107 | 0.219 | 0.144 | Succinate dehydrogenase inhibitor | 0.144 0.125 DBMET00258 | DBMET00258 | |
| 0.089 | 0.201 | 0.346 | Platelet adhesion inhibitor | 0.191 0.076 DBMET00763 0.342 0.022 DBMET00762 0.202 0.07 DBMET01360 0.3 0.034 DBMET00926 0.346 0.02 DBMET00925 | DBMET00925 | |
| 0.029 | 0.141 | 0.092 | Heparanase inhibitor | 0.05 0.044 DBMET00763 0.081 0.006 DBMET00762 0.054 0.036 DBMET00926 0.092 0.004 DBMET00925 | DBMET00925 | |
| 0.073 | 0.187 | 0.134 | Interleukin 4 antagonist | 0.134 0.067 DBMET00258 0.124 0.08 DBMET00411 0.117 0.089 DBMET00762 0.124 0.08 DBMET01361 0.126 0.076 DBMET00925 | DBMET00258 | |
| 0.022 | 0.137 | 0.065 | Alcohol oxidase inhibitor | 0.065 0.032 DBMET00411 | DBMET00411 | |
| 0.012 | 0.126 | 0.077 | Sigma receptor antagonist | 0.059 0.029 DBMET01361 0.077 0.021 DBMET01362 | DBMET01362 | |
| 0.034 | 0.149 | 0.065 | NMDA receptor agonist | 0.065 0.04 DBMET00926 | DBMET00926 | |
| 0.061 | 0.176 | 0.171 | Acetylcholine antagonist | 0.155 0.047 DBMET01361 0.171 0.04 DBMET01362 | DBMET01362 | |
| 0.163 | 0.279 | 0.218 | Ca(v)3.3 blocker | 0.218 0.155 DBMET01362 | DBMET01362 | |
| 0.061 | 0.177 | 0.177 | Cholinergic antagonist | 0.162 0.046 DBMET01361 0.177 0.039 DBMET01362 | DBMET01362 | |
| 0.059 | 0.176 | 0.086 | D-Ala-D-Ala ligase inhibitor | 0.086 0.053 DBMET01360 0.078 0.076 DBMET01361 | DBMET01360 | |
| 0.021 | 0.139 | 0.077 | Cyclin B2 inhibitor | 0.077 0.016 DBMET01360 | DBMET01360 | |
| 0.088 | 0.206 | 0.165 | EphB2 antagonist | 0.154 0.126 DBMET01361 0.165 0.115 DBMET01362 | DBMET01362 | |
| 0.017 | 0.135 | 0.031 | LIM domain kinase 2 inhibitor | 0.031 0.021 DBMET01362 | DBMET01362 | |
| 0.021 | 0.139 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | 0.042 0.033 DBMET01360 | DBMET01360 | |
| 0.052 | 0.171 | 0.18 | GABA C receptor agonist | 0.18 0.025 DBMET01359 0.111 0.056 DBMET00411 0.149 0.034 DBMET01360 0.142 0.037 DBMET01361 0.148 0.035 DBMET01362 | DBMET01359 | |
| 0.024 | 0.143 | 0.207 | 5 Hydroxytryptamine 3 antagonist | 0.076 0.026 DBMET01359 0.061 0.034 DBMET01361 0.207 0.005 DBMET01362 | DBMET01362 | |
| 0.015 | 0.135 | 0.041 | Oxytocin agonist | 0.041 0.031 DBMET01361 | DBMET01361 | |
| 0.034 | 0.156 | 0.107 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.07 0.061 DBMET00258 0.072 0.059 DBMET01360 0.107 0.034 DBMET01361 0.066 0.065 DBMET01362 | DBMET01361 | |
| 0.051 | 0.174 | 0.212 | UDP-glucose 4-epimerase inhibitor | 0.098 0.063 DBMET00411 0.117 0.045 DBMET00762 0.212 0.017 DBMET00925 | DBMET00925 | |
| 0.06 | 0.183 | 0.204 | Multidrug resistance-associated protein 1 inhibitor | 0.186 0.014 DBMET00763 0.096 0.086 DBMET00762 0.204 0.009 DBMET00926 | DBMET00926 | |
| 0.131 | 0.253 | 0.227 | RNA-directed DNA polymerase inhibitor | 0.191 0.113 DBMET00258 0.167 0.159 DBMET01359 0.172 0.148 DBMET00411 0.227 0.067 DBMET00763 0.186 0.122 DBMET01361 0.215 0.08 DBMET00926 0.169 0.155 DBMET01362 | DBMET00763 | |
| 0.015 | 0.139 | 0.061 | Geranyltranstransferase inhibitor | 0.051 0.021 DBMET01361 0.061 0.013 DBMET01362 | DBMET01362 | |
| 0.025 | 0.15 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.039 DBMET00411 0.05 0.043 DBMET01361 | DBMET00411 | |
| 0.026 | 0.151 | 0.058 | Dopamine beta hydroxylase inhibitor | 0.058 0.018 DBMET01359 0.049 0.032 DBMET01361 | DBMET01359 | |
| 0.021 | 0.147 | 0.069 | Acetylcholine M3 receptor antagonist | 0.069 0.032 DBMET01361 0.064 0.037 DBMET01362 | DBMET01361 | |
| 0.008 | 0.135 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 DBMET01361 | DBMET01361 | |
| 0.073 | 0.201 | 0.125 | CDC-like kinase 4 inhibitor | 0.125 0.122 DBMET01362 | DBMET01362 | |
| 0.051 | 0.179 | 0.24 | Triose-phosphate isomerase inhibitor | 0.08 0.076 DBMET00411 0.105 0.043 DBMET00763 0.085 0.068 DBMET00762 0.24 0.007 DBMET00926 0.147 0.021 DBMET00925 0.08 0.077 DBMET01362 | DBMET00926 | |
| 0.04 | 0.169 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.045 DBMET01359 0.081 0.035 DBMET01362 | DBMET01362 | |
| 0.088 | 0.218 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.142 0.138 DBMET01359 0.148 0.132 DBMET01360 | DBMET01360 | |
| 0.026 | 0.158 | 0.082 | Cyclin B1 inhibitor | 0.082 0.02 DBMET01360 | DBMET01360 | |
| 0.028 | 0.161 | 0.143 | Check point kinase 1 inhibitor | 0.066 0.049 DBMET01359 0.143 0.016 DBMET01360 0.064 0.053 DBMET01361 | DBMET01360 | |
| 0.018 | 0.151 | 0.057 | NMDA receptor subunit 3B antagonist | 0.039 0.036 DBMET00411 0.042 0.033 DBMET01360 0.057 0.02 DBMET01361 | DBMET01361 | |
| 0.027 | 0.161 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.073 0.014 DBMET00762 0.066 0.019 DBMET00925 | DBMET00762 | |
| 0.052 | 0.189 | 0.09 | Bile acid receptor antagonist | 0.09 0.073 DBMET01361 | DBMET01361 | |
| 0.012 | 0.148 | 0.049 | Carbonic anhydrase I inhibitor | 0.049 0.044 DBMET00926 | DBMET00926 | |
| 0.017 | 0.153 | 0.048 | Estrogen-related receptor beta antagonist | 0.031 0.026 DBMET00411 0.048 0.006 DBMET01361 | DBMET01361 | |
| 0.023 | 0.16 | 0.072 | Cyclin B inhibitor | 0.072 0.02 DBMET01360 | DBMET01360 | |
| 0.047 | 0.185 | 0.182 | Topoisomerase II inhibitor | 0.179 0.038 DBMET00762 0.094 0.092 DBMET01360 0.152 0.049 DBMET01361 0.182 0.038 DBMET00925 | DBMET00925 | |
| 0.039 | 0.178 | 0.061 | Lipocortins synthesis agonist | 0.059 0.039 DBMET00762 0.061 0.033 DBMET00925 | DBMET00925 | |
| 0.053 | 0.192 | 0.126 | DNA polymerase I inhibitor | 0.125 0.065 DBMET00762 0.126 0.064 DBMET00925 | DBMET00925 | |
| 0.087 | 0.227 | 0.153 | Dyrk kinase inhibitor | 0.153 0.133 DBMET01359 0.151 0.134 DBMET01360 | DBMET01359 | |
| 0.027 | 0.167 | 0.07 | Topoisomerase II beta inhibitor | 0.07 0.017 DBMET01361 0.05 0.033 DBMET01362 | DBMET01361 | |
| 0.004 | 0.144 | 0.015 | NMDA receptor phencyclidine site antagonist | 0.015 0.01 DBMET01361 0.014 0.012 DBMET01362 | DBMET01361 | |
| 0.054 | 0.196 | 0.179 | Alkylator | 0.179 0.033 DBMET00762 0.113 0.075 DBMET01361 0.147 0.048 DBMET00925 | DBMET00762 | |
| 0.061 | 0.204 | 0.096 | Glutamate release inhibitor | 0.085 0.076 DBMET01359 0.096 0.05 DBMET01360 | DBMET01360 | |
| 0.01 | 0.154 | 0.062 | NMDA 2D receptor antagonist | 0.05 0.007 DBMET00763 0.062 0.005 DBMET00926 | DBMET00926 | |
| 0.025 | 0.168 | 0.057 | Androgen agonist | 0.057 0.045 DBMET01361 | DBMET01361 | |
| 0.076 | 0.22 | 0.106 | Interleukin 2 antagonist | 0.106 0.073 DBMET01362 | DBMET01362 | |
| 0.102 | 0.247 | 0.152 | Phospholipase C inhibitor | 0.145 0.118 DBMET01359 0.151 0.105 DBMET00411 0.145 0.116 DBMET01360 0.15 0.106 DBMET01361 0.152 0.102 DBMET00926 | DBMET00926 | |
| 0.036 | 0.181 | 0.068 | Calcium channel L-type blocker | 0.068 0.056 DBMET01362 | DBMET01362 | |
| 0.007 | 0.152 | 0.143 | Imidazoline I1 receptor antagonist | 0.023 0.011 DBMET01359 0.143 0.002 DBMET01360 | DBMET01360 | |
| 0.009 | 0.155 | 0.066 | Dopamine D5 antagonist | 0.066 0.016 DBMET01360 0.041 0.031 DBMET01361 | DBMET01360 | |
| 0.031 | 0.177 | 0.111 | Cathepsin G inhibitor | 0.111 0.029 DBMET00926 | DBMET00926 | |
| 0.033 | 0.18 | 0.071 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.071 0.027 DBMET01360 | DBMET01360 | |
| 0.069 | 0.215 | 0.27 | Protein-tyrosine phosphatase inhibitor | 0.204 0.045 DBMET00763 0.27 0.026 DBMET00926 0.125 0.107 DBMET00925 | DBMET00926 | |
| 0.052 | 0.199 | 0.114 | Xanthine oxidase inhibitor | 0.114 0.051 DBMET00762 0.112 0.051 DBMET00925 | DBMET00762 | |
| 0.008 | 0.155 | 0.031 | AMPA 3 receptor antagonist | 0.031 0.019 DBMET01362 | DBMET01362 | |
| 0.082 | 0.23 | 0.217 | Insulin secretagoues | 0.185 0.045 DBMET00762 0.217 0.028 DBMET00925 | DBMET00925 | |
| 0.111 | 0.259 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.133 0.102 DBMET01361 0.136 0.09 DBMET01362 | DBMET01362 | |
| 0.04 | 0.189 | 0.12 | Pim-3 kinase inhibitor | 0.088 0.062 DBMET01359 0.08 0.076 DBMET01360 0.093 0.054 DBMET01361 0.12 0.031 DBMET01362 | DBMET01362 | |
| 0.031 | 0.18 | 0.065 | Aminopeptidase I inhibitor | 0.065 0.061 DBMET00411 | DBMET00411 | |
| 0.031 | 0.18 | 0.047 | Factor III inhibitor | 0.047 0.042 DBMET00762 | DBMET00762 | |
| 0.051 | 0.201 | 0.086 | Bromodomain-containing protein 2 inhibitor | 0.086 0.063 DBMET01360 0.08 0.078 DBMET01362 | DBMET01360 | |
| 0.035 | 0.187 | 0.065 | Glutamate (mGluR7) antagonist | 0.065 0.052 DBMET01360 | DBMET01360 | |
| 0.007 | 0.16 | 0.035 | Nicotinic alpha3beta4 receptor agonist | 0.035 0.015 DBMET01360 | DBMET01360 | |
| 0.024 | 0.177 | 0.058 | Phosphodiesterase III inhibitor | 0.058 0.054 DBMET01360 | DBMET01360 | |
| 0.01 | 0.165 | 0.067 | Factor Xa inhibitor | 0.067 0.021 DBMET00926 | DBMET00926 | |
| 0.05 | 0.206 | 0.137 | Acetylcholine muscarinic antagonist | 0.126 0.061 DBMET01361 0.137 0.052 DBMET01362 | DBMET01362 | |
| 0.086 | 0.241 | 0.184 | Interleukin 6 antagonist | 0.168 0.066 DBMET00762 0.135 0.114 DBMET01361 0.184 0.052 DBMET00925 | DBMET00925 | |
| 0.03 | 0.186 | 0.081 | Phospholipase D inhibitor | 0.081 0.033 DBMET01362 | DBMET01362 | |
| 0.032 | 0.189 | 0.311 | MAP-kinase-activated kinase 2 inhibitor | 0.311 0.004 DBMET01360 | DBMET01360 | |
| 0.02 | 0.178 | 0.068 | Pim-2 kinase inhibitor | 0.058 0.032 DBMET01359 0.051 0.044 DBMET01360 0.049 0.048 DBMET01361 0.068 0.025 DBMET01362 | DBMET01362 | |
| 0.039 | 0.197 | 0.096 | Cyclin-dependent kinase 5 inhibitor | 0.096 0.078 DBMET01360 | DBMET01360 | |
| 0.16 | 0.318 | 0.28 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.146 DBMET01359 0.28 0.036 DBMET01360 0.198 0.172 DBMET01361 0.239 0.08 DBMET01362 | DBMET01360 | |
| 0.042 | 0.2 | 0.072 | Chymotrypsin inhibitor | 0.072 0.067 DBMET00926 | DBMET00926 | |
| 0.023 | 0.184 | 0.112 | MAO B inhibitor | 0.112 0.054 DBMET01359 0.087 0.068 DBMET01361 | DBMET01359 | |
| 0.022 | 0.183 | 0.043 | Purinergic P2X4 antagonist | 0.043 0.038 DBMET01360 | DBMET01360 | |
| 0.095 | 0.256 | 0.205 | Neurotrophic factor enhancer | 0.162 0.121 DBMET00411 0.205 0.071 DBMET01360 0.166 0.115 DBMET01361 0.167 0.114 DBMET00925 | DBMET01360 | |
| 0.033 | 0.196 | 0.109 | Acetylcholine nicotinic agonist | 0.071 0.069 DBMET01361 0.109 0.031 DBMET01362 | DBMET01362 | |
| 0.088 | 0.251 | 0.255 | Non-steroidal antiinflammatory agent | 0.255 0.041 DBMET00762 0.208 0.065 DBMET00925 | DBMET00762 | |
| 0.022 | 0.186 | 0.087 | Myc inhibitor | 0.087 0.01 DBMET01360 | DBMET01360 | |
| 0.078 | 0.243 | 0.299 | Dual specificity phosphatase inhibitor | 0.135 0.112 DBMET00258 0.299 0.029 DBMET00763 0.143 0.103 DBMET01361 0.286 0.031 DBMET00926 | DBMET00763 | |
| 0.024 | 0.19 | 0.167 | Histamine H1 receptor antagonist | 0.074 0.064 DBMET01360 0.087 0.051 DBMET01361 0.167 0.02 DBMET01362 | DBMET01362 | |
| 0.025 | 0.192 | 0.085 | Porphobilinogen synthase inhibitor | 0.085 0.044 DBMET00411 0.07 0.056 DBMET01361 | DBMET00411 | |
| 0.055 | 0.222 | 0.142 | Toll-Like receptor 4 antagonist | 0.136 0.03 DBMET00762 0.142 0.026 DBMET00925 | DBMET00925 | |
| 0.043 | 0.21 | 0.11 | Glycogen synthase kinase-3 alpha inhibitor | 0.11 0.094 DBMET01359 | DBMET01359 | |
| 0.015 | 0.183 | 0.123 | NMDA 2 receptor antagonist | 0.071 0.05 DBMET01359 0.073 0.048 DBMET00411 0.123 0.023 DBMET01361 0.099 0.032 DBMET00926 0.07 0.051 DBMET01362 | DBMET01361 | |
| 0.01 | 0.178 | 0.055 | AMPA receptor antagonist | 0.055 0.028 DBMET01362 | DBMET01362 | |
| 0.025 | 0.193 | 0.151 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.074 0.055 DBMET01359 0.151 0.019 DBMET01360 | DBMET01360 | |
| 0.039 | 0.207 | 0.132 | Antihistaminic | 0.132 0.038 DBMET01362 | DBMET01362 | |
| 0.019 | 0.188 | 0.048 | Nicotinic receptor alpha4 subunit antagonist | 0.048 0.036 DBMET01360 | DBMET01360 | |
| 0.035 | 0.206 | 0.097 | M18 aspartyl aminopeptidase inhibitor | 0.097 0.095 DBMET00258 | DBMET00258 | |
| 0.009 | 0.182 | 0.041 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 DBMET00762 0.041 0.007 DBMET00925 | DBMET00925 | |
| 0.037 | 0.21 | 0.341 | MAP-kinase-activated kinase inhibitor | 0.341 0.004 DBMET01360 | DBMET01360 | |
| 0.098 | 0.271 | 0.28 | Cardiotonic | 0.229 0.096 DBMET01361 0.28 0.065 DBMET01362 | DBMET01362 | |
| 0.031 | 0.205 | 0.124 | Histamine antagonist | 0.124 0.037 DBMET01362 | DBMET01362 | |
| 0.005 | 0.18 | 0.033 | Endothelial nitric-oxide synthase inhibitor | 0.033 0.019 DBMET01362 | DBMET01362 | |
| 0.033 | 0.209 | 0.073 | I kappa B kinase inhibitor | 0.073 0.072 DBMET01359 | DBMET01359 | |
| 0.13 | 0.306 | 0.322 | Antiobesity | 0.204 0.203 DBMET01360 0.322 0.102 DBMET00926 0.26 0.147 DBMET00925 | DBMET00926 | |
| 0.014 | 0.19 | 0.043 | Phosphodiesterase 4A inhibitor | 0.043 0.041 DBMET01360 | DBMET01360 | |
| 0.044 | 0.222 | 0.088 | Anabolic | 0.088 0.082 DBMET00926 | DBMET00926 | |
| 0.01 | 0.19 | 0.089 | Carbonic anhydrase inhibitor | 0.089 0.031 DBMET00926 | DBMET00926 | |
| 0.082 | 0.263 | 0.272 | Platelet antagonist | 0.244 0.075 DBMET00762 0.229 0.082 DBMET01360 0.272 0.063 DBMET00925 | DBMET00925 | |
| 0.05 | 0.232 | 0.115 | Transcription factor NF kappa B stimulant | 0.115 0.028 DBMET00762 0.115 0.028 DBMET00925 | DBMET00925 | |
| 0.023 | 0.205 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.097 0.034 DBMET01360 0.08 0.05 DBMET01362 | DBMET01360 | |
| 0.038 | 0.222 | 0.131 | Aurora-B kinase inhibitor | 0.131 0.056 DBMET01360 | DBMET01360 | |
| 0.067 | 0.254 | 0.164 | Protein kinase (CK1) gamma 3 inhibitor | 0.164 0.075 DBMET01359 0.127 0.117 DBMET01362 | DBMET01359 | |
| 0.098 | 0.286 | 0.534 | Hypoglycemic | 0.484 0.017 DBMET00762 0.321 0.046 DBMET01360 0.534 0.013 DBMET00925 | DBMET00925 | |
| 0.024 | 0.213 | 0.068 | Protein kinase C iota inhibitor | 0.068 0.034 DBMET01360 | DBMET01360 | |
| 0.006 | 0.196 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 DBMET00762 0.038 0.009 DBMET00925 | DBMET00925 | |
| 0.013 | 0.204 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 DBMET01361 0.028 0.022 DBMET01362 | DBMET01361 | |
| 0.075 | 0.267 | 0.152 | DNA repair enzyme inhibitor | 0.146 0.035 DBMET00762 0.107 0.106 DBMET01360 0.152 0.03 DBMET00925 | DBMET00925 | |
| 0.02 | 0.211 | 0.055 | Calcium channel T-type blocker | 0.055 0.046 DBMET01362 | DBMET01362 | |
| 0.048 | 0.241 | 0.186 | Cyclin-dependent kinase 7 inhibitor | 0.186 0.039 DBMET01360 0.145 0.063 DBMET01362 | DBMET01360 | |
| 0.029 | 0.224 | 0.112 | CDC25A inhibitor | 0.104 0.025 DBMET00763 0.112 0.022 DBMET00926 | DBMET00926 | |
| 0.019 | 0.214 | 0.068 | CDC7 inhibitor | 0.063 0.053 DBMET01360 0.068 0.046 DBMET01362 | DBMET01362 | |
| 0.021 | 0.217 | 0.104 | Protein kinase C beta inhibitor | 0.104 0.012 DBMET01360 0.096 0.015 DBMET01361 0.102 0.013 DBMET01362 | DBMET01360 | |
| 0.064 | 0.26 | 0.272 | Cell wall synthesis inhibitor | 0.115 0.107 DBMET00411 0.145 0.071 DBMET00763 0.192 0.033 DBMET00762 0.237 0.019 DBMET00926 0.272 0.012 DBMET00925 | DBMET00925 | |
| 0.059 | 0.256 | 0.118 | Protein kinase (CK1) gamma 1 inhibitor | 0.118 0.1 DBMET01359 | DBMET01359 | |
| 0.013 | 0.21 | 0.051 | Leukocyte elastase inhibitor | 0.051 0.023 DBMET00926 | DBMET00926 | |
| 0.073 | 0.271 | 0.338 | Hepatoprotectant | 0.338 0.021 DBMET00762 0.337 0.021 DBMET00925 | DBMET00762 | |
| 0.009 | 0.207 | 0.036 | NMDA receptor subunit 3A antagonist | 0.036 0.028 DBMET01361 | DBMET01361 | |
| 0.056 | 0.255 | 0.125 | Calcium channel blocker | 0.125 0.082 DBMET01362 | DBMET01362 | |
| 0.008 | 0.208 | 0.057 | Melanin-concentrating hormone receptor 1 antagonist | 0.057 0.032 DBMET01360 | DBMET01360 | |
| 0.015 | 0.216 | 0.044 | AMPA 4 receptor antagonist | 0.038 0.031 DBMET01361 0.044 0.021 DBMET01362 | DBMET01362 | |
| 0.087 | 0.29 | 0.15 | Death-associated protein kinase 1 inhibitor | 0.15 0.04 DBMET01360 | DBMET01360 | |
| 0.011 | 0.215 | 0.033 | Protein kinase C beta II inhibitor | 0.031 0.028 DBMET01360 0.033 0.02 DBMET01361 0.033 0.02 DBMET01362 | DBMET01362 | |
| 0.018 | 0.223 | 0.126 | HIV-1 integrase (3'-Processing) inhibitor | 0.115 0.021 DBMET00763 0.126 0.018 DBMET00926 | DBMET00926 | |
| 0.052 | 0.259 | 0.204 | Activin receptor-like kinase 2 inhibitor | 0.204 0.035 DBMET01360 | DBMET01360 | |
| 0.011 | 0.219 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.044 DBMET01359 0.057 0.05 DBMET01361 | DBMET01359 | |
| 0.022 | 0.23 | 0.146 | Toll-Like receptor 7 antagonist | 0.146 0.006 DBMET01360 | DBMET01360 | |
| 0.066 | 0.277 | 0.208 | Anticonvulsant | 0.208 0.077 DBMET01362 | DBMET01362 | |
| 0.014 | 0.226 | 0.13 | Antineoplastic antibiotic | 0.13 0.036 DBMET00762 0.126 0.037 DBMET00925 | DBMET00762 | |
| 0.055 | 0.267 | 0.08 | T cell inhibitor | 0.08 0.065 DBMET00925 | DBMET00925 | |
| 0.104 | 0.316 | 0.302 | DNA synthesis inhibitor | 0.269 0.056 DBMET00762 0.193 0.134 DBMET01360 0.212 0.105 DBMET01361 0.302 0.043 DBMET00925 0.186 0.144 DBMET01362 | DBMET00925 | |
| 0.004 | 0.216 | 0.087 | Estrone sulfatase inhibitor | 0.023 0.014 DBMET00763 0.087 0.005 DBMET00926 | DBMET00926 | |
| 0.017 | 0.23 | 0.065 | Alpha-mannosidase inhibitor | 0.053 0.037 DBMET00762 0.065 0.021 DBMET00925 | DBMET00925 | |
| 0.062 | 0.276 | 0.175 | Anesthetic general | 0.175 0.09 DBMET01361 0.161 0.103 DBMET01362 | DBMET01361 | |
| 0.023 | 0.238 | 0.04 | Alpha 1L adrenoreceptor agonist | 0.04 0.038 DBMET01360 | DBMET01360 | |
| 0.027 | 0.244 | 0.07 | Protein kinase B beta inhibitor | 0.069 0.059 DBMET01359 0.07 0.057 DBMET01362 | DBMET01362 | |
| 0.065 | 0.284 | 0.196 | Hexokinase inhibitor | 0.16 0.067 DBMET00762 0.196 0.038 DBMET00925 | DBMET00925 | |
| 0.012 | 0.232 | 0.147 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.147 0.005 DBMET01360 | DBMET01360 | |
| 0.024 | 0.245 | 0.127 | Anesthetic local | 0.095 0.088 DBMET01361 0.127 0.062 DBMET01362 | DBMET01362 | |
| 0.013 | 0.235 | 0.09 | Toll-Like receptor 8 antagonist | 0.055 0.036 DBMET01359 0.09 0.013 DBMET01360 0.053 0.038 DBMET01362 | DBMET01360 | |
| 0.061 | 0.282 | 0.136 | Arachidonic acid antagonist | 0.136 0.105 DBMET01360 0.13 0.113 DBMET01361 | DBMET01360 | |
| 0.019 | 0.243 | 0.082 | Adrenaline uptake inhibitor | 0.082 0.026 DBMET01360 0.054 0.052 DBMET01361 0.081 0.026 DBMET01362 | DBMET01360 | |
| 0.039 | 0.263 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.04 DBMET01361 | DBMET01361 | |
| 0.042 | 0.267 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.05 DBMET00925 | DBMET00925 | |
| 0.029 | 0.255 | 0.105 | Pim-1 kinase inhibitor | 0.105 0.053 DBMET01359 0.085 0.074 DBMET01360 0.089 0.069 DBMET01362 | DBMET01359 | |
| 0.044 | 0.273 | 0.097 | Calcium channel (voltage-sensitive) blocker | 0.097 0.089 DBMET01362 | DBMET01362 | |
| 0.014 | 0.246 | 0.149 | Poly(ADP-ribose) polymerase inhibitor | 0.149 0.005 DBMET01360 | DBMET01360 | |
| 0.034 | 0.265 | 0.102 | Cholesterol synthesis inhibitor | 0.102 0.084 DBMET01361 | DBMET01361 | |
| 0.028 | 0.26 | 0.074 | HIV-1 integrase inhibitor | 0.064 0.057 DBMET00763 0.074 0.044 DBMET00926 | DBMET00926 | |
| 0.024 | 0.258 | 0.138 | Check point kinase 2 inhibitor | 0.138 0.036 DBMET01360 | DBMET01360 | |
| 0.035 | 0.273 | 0.091 | Cystathionine beta-synthase inhibitor | 0.091 0.089 DBMET01361 | DBMET01361 | |
| 0.021 | 0.259 | 0.091 | Protein kinase C alpha inhibitor | 0.091 0.026 DBMET01360 0.061 0.058 DBMET01362 | DBMET01360 | |
| 0.022 | 0.262 | 0.179 | Cyclin B3 inhibitor | 0.179 0.009 DBMET01360 | DBMET01360 | |
| 0.023 | 0.264 | 0.091 | Thrombin inhibitor | 0.069 0.056 DBMET00763 0.091 0.032 DBMET00926 | DBMET00926 | |
| 0.034 | 0.278 | 0.09 | Ferrochelatase inhibitor | 0.09 0.083 DBMET01362 | DBMET01362 | |
| 0.015 | 0.259 | 0.071 | Dopamine uptake inhibitor | 0.071 0.03 DBMET01362 | DBMET01362 | |
| 0.059 | 0.304 | 0.187 | Cyclin-dependent kinase 8 inhibitor | 0.148 0.081 DBMET01361 0.187 0.046 DBMET01362 | DBMET01362 | |
| 0.011 | 0.256 | 0.055 | Mannosidase inhibitor | 0.055 0.021 DBMET00925 | DBMET00925 | |
| 0.026 | 0.275 | 0.091 | Alcohol dehydrogenase inhibitor | 0.091 0.063 DBMET01361 | DBMET01361 | |
| 0.05 | 0.299 | 0.416 | Anticoagulant | 0.289 0.03 DBMET00763 0.175 0.064 DBMET00762 0.129 0.102 DBMET01360 0.416 0.015 DBMET00926 0.206 0.051 DBMET00925 | DBMET00926 | |
| 0.012 | 0.261 | 0.114 | HIV-1 integrase (Strand Transfer) inhibitor | 0.114 0.018 DBMET00763 0.101 0.022 DBMET00926 | DBMET00763 | |
| 0.008 | 0.259 | 0.051 | Phosphorylase inhibitor | 0.051 0.029 DBMET00925 | DBMET00925 | |
| 0.04 | 0.291 | 0.229 | Amylase inhibitor | 0.229 0.034 DBMET00762 0.223 0.036 DBMET00925 | DBMET00762 | |
| 0.031 | 0.285 | 0.123 | Creatine kinase inhibitor | 0.115 0.045 DBMET00411 0.123 0.039 DBMET01361 | DBMET01361 | |
| 0.018 | 0.274 | 0.113 | Phosphodiesterase IV inhibitor | 0.113 0.037 DBMET01360 | DBMET01360 | |
| 0.041 | 0.303 | 0.106 | Lanosterol 14 alpha demethylase inhibitor | 0.097 0.06 DBMET01359 0.095 0.064 DBMET01361 0.106 0.047 DBMET01362 | DBMET01362 | |
| 0.016 | 0.284 | 0.07 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 DBMET01360 0.07 0.06 DBMET01361 | DBMET01361 | |
| 0.014 | 0.283 | 0.068 | Phosphodiesterase 4B inhibitor | 0.068 0.046 DBMET01360 | DBMET01360 | |
| 0.09 | 0.363 | 0.3 | Cholesterol antagonist | 0.203 0.162 DBMET00762 0.3 0.091 DBMET00925 | DBMET00925 | |
| 0.005 | 0.277 | 0.115 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.115 0.005 DBMET01360 | DBMET01360 | |
| 0.048 | 0.324 | 0.324 | Diuretic | 0.324 0.019 DBMET00926 0.17 0.061 DBMET00925 | DBMET00926 | |
| 0.022 | 0.302 | 0.088 | ALK inhibitor | 0.088 0.05 DBMET01360 | DBMET01360 | |
| 0.086 | 0.366 | 0.422 | Immunosuppressant | 0.403 0.062 DBMET00762 0.422 0.055 DBMET00925 | DBMET00925 | |
| 0.034 | 0.315 | 0.102 | Phosphodiesterase I inhibitor | 0.102 0.042 DBMET01360 | DBMET01360 | |
| 0.007 | 0.289 | 0.033 | Protein 30S ribosomal subunit inhibitor | 0.027 0.014 DBMET00762 0.033 0.012 DBMET00925 | DBMET00925 | |
| 0.032 | 0.315 | 0.089 | Cell adhesion molecule inhibitor | 0.084 0.048 DBMET00762 0.089 0.043 DBMET00925 | DBMET00925 | |
| 0.013 | 0.297 | 0.071 | Elastase inhibitor | 0.054 0.036 DBMET00763 0.071 0.021 DBMET00926 | DBMET00926 | |
| 0.017 | 0.302 | 0.067 | Cyclin-dependent kinase 4 inhibitor | 0.067 0.044 DBMET01360 | DBMET01360 | |
| 0.043 | 0.334 | 0.136 | Estrogen antagonist | 0.118 0.059 DBMET00411 0.136 0.031 DBMET01361 | DBMET01361 | |
| 0.013 | 0.306 | 0.198 | NMDA 2B receptor antagonist | 0.179 0.007 DBMET00763 0.198 0.006 DBMET00926 | DBMET00926 | |
| 0.023 | 0.317 | 0.048 | Phosphodiesterase 6C inhibitor | 0.048 0.028 DBMET01360 | DBMET01360 | |
| 0.015 | 0.311 | 0.062 | Antibiotic Aminoglycoside-like | 0.058 0.009 DBMET00762 0.062 0.008 DBMET00925 | DBMET00925 | |
| 0.014 | 0.311 | 0.061 | Acid-sensing ion channel blocker | 0.061 0.009 DBMET01360 | DBMET01360 | |
| 0.034 | 0.336 | 0.162 | MAP kinase 12 inhibitor | 0.162 0.035 DBMET01360 | DBMET01360 | |
| 0.005 | 0.316 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.035 0.006 DBMET00763 0.033 0.009 DBMET00926 | DBMET00763 | |
| 0.034 | 0.349 | 0.136 | MAP kinase 13 inhibitor | 0.136 0.044 DBMET01360 | DBMET01360 | |
| 0.005 | 0.325 | 0.055 | Estrogen agonist | 0.055 0.032 DBMET00926 | DBMET00926 | |
| 0.026 | 0.35 | 0.103 | Cyclin-dependent kinase inhibitor | 0.103 0.087 DBMET01360 | DBMET01360 | |
| 0.039 | 0.365 | 0.267 | Dual specificity phosphatase 3 inhibitor | 0.267 0.035 DBMET00763 0.234 0.046 DBMET00926 | DBMET00763 | |
| 0.027 | 0.353 | 0.06 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET00763 0.06 0.027 DBMET00926 0.054 0.042 DBMET00925 | DBMET00926 | |
| 0.017 | 0.347 | 0.079 | Acetylcholine agonist | 0.079 0.067 DBMET01362 | DBMET01362 | |
| 0.016 | 0.348 | 0.136 | Aurora-A kinase inhibitor | 0.136 0.046 DBMET01360 | DBMET01360 | |
| 0.004 | 0.339 | 0.034 | Factor XI inhibitor | 0.034 0.024 DBMET00763 | DBMET00763 | |
| 0.022 | 0.357 | 0.054 | Phosphodiesterase 1B inhibitor | 0.054 0.052 DBMET01360 | DBMET01360 | |
| 0.019 | 0.356 | 0.073 | Factor IXa inhibitor | 0.052 0.035 DBMET00763 0.047 0.041 DBMET00762 0.073 0.019 DBMET00926 0.066 0.022 DBMET00925 | DBMET00926 | |
| 0.039 | 0.377 | 0.168 | Cell adhesion inhibitor | 0.16 0.041 DBMET00762 0.168 0.036 DBMET00925 | DBMET00925 | |
| 0.007 | 0.348 | 0.051 | Phosphodiesterase 2A inhibitor | 0.051 0.033 DBMET01360 | DBMET01360 | |
| 0.123 | 0.469 | 0.34 | MAP kinase kinase 6 inhibitor | 0.27 0.166 DBMET01360 0.26 0.178 DBMET01361 0.34 0.1 DBMET01362 | DBMET01362 | |
| 0.006 | 0.354 | 0.063 | Phosphodiesterase II inhibitor | 0.063 0.029 DBMET01360 | DBMET01360 | |
| 0.027 | 0.391 | 0.115 | Estrogen receptor beta antagonist | 0.102 0.061 DBMET00411 0.115 0.038 DBMET01361 | DBMET01361 | |
| 0.121 | 0.486 | 0.186 | MAP kinase kinase 3 inhibitor | 0.186 0.168 DBMET01362 | DBMET01362 | |
| 0.022 | 0.39 | 0.12 | MAP kinase 9 inhibitor | 0.12 0.049 DBMET01360 | DBMET01360 | |
| 0.004 | 0.375 | 0.035 | Kinesin-like protein 1 inhibitor | 0.035 0.028 DBMET01360 | DBMET01360 | |
| 0.004 | 0.375 | 0.035 | Kinesin antagonist | 0.035 0.028 DBMET01360 | DBMET01360 | |
| 0.051 | 0.429 | 0.211 | NOS3 expression enhancer | 0.163 0.061 DBMET00762 0.211 0.037 DBMET00925 | DBMET00925 | |
| 0.026 | 0.405 | 0.175 | Phosphodiesterase inhibitor | 0.175 0.044 DBMET01360 | DBMET01360 | |
| 0.019 | 0.403 | 0.061 | Phosphodiesterase 1A inhibitor | 0.061 0.04 DBMET01360 | DBMET01360 | |
| 0.011 | 0.395 | 0.12 | Phosphodiesterase V inhibitor | 0.12 0.019 DBMET01360 | DBMET01360 | |
| 0.07 | 0.459 | 0.202 | MAP-kinase-activated kinase 5 inhibitor | 0.202 0.101 DBMET01360 0.186 0.123 DBMET01361 0.182 0.128 DBMET01362 | DBMET01360 | |
| 0.011 | 0.4 | 0.116 | Phosphodiesterase 5A inhibitor | 0.116 0.02 DBMET01360 | DBMET01360 | |
| 0.011 | 0.416 | 0.063 | Phenylethanolamine N methyltransferase inhibitor | 0.063 0.006 DBMET01360 | DBMET01360 | |
| 0.068 | 0.49 | 0.361 | Immunomodulator | 0.295 0.085 DBMET00762 0.361 0.056 DBMET00925 | DBMET00925 | |
| 0.012 | 0.438 | 0.155 | MAP kinase 11 inhibitor | 0.155 0.016 DBMET01360 | DBMET01360 | |
| 0.072 | 0.512 | 0.222 | Analgesic | 0.222 0.212 DBMET01362 | DBMET01362 | |
| 0.01 | 0.498 | 0.037 | Purinergic P2Y2 antagonist | 0.037 0.019 DBMET00926 | DBMET00926 | |
| 0.017 | 0.54 | 0.241 | Potassium channel (Voltage-sensitive) blocker | 0.241 0.072 DBMET01360 | DBMET01360 | |
| 0.013 | 0.563 | 0.259 | HERG channel blocker | 0.259 0.063 DBMET01360 | DBMET01360 | |
| 0.055 | 0.618 | 0.635 | Cyclophilin D inhibitor | 0.562 0.035 DBMET00762 0.635 0.022 DBMET00925 | DBMET00925 | |
| 0.017 | 0.595 | 0.148 | Hypolipemic | 0.148 0.138 DBMET00925 | DBMET00925 | |
| 0.05 | 0.683 | 0.599 | Antiinflammatory | 0.568 0.063 DBMET00762 0.599 0.054 DBMET00925 | DBMET00925 | |
| 0.061 | 0.795 | 0.124 | CC chemokine 6 receptor antagonist | 0.124 0.098 DBMET00762 0.124 0.098 DBMET00925 | DBMET00925 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |